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Liver cancer is the fifth most common form of cancer worldwide
[1], with an incidence rate almost equals the mortality rate and
ranks 3rd among causes of cancer related death [2]. The coexist-
ence of two life threatening conditions, cancer and liver cirrhosis
makes the staging challenging. However, there are some staging
systems, e.g. the Barcelona staging system for Hepatocellular car-
cinoma (HCC) [3], that suggest treatment options and manage-
ment. Whereas diagnosis in early stages gives hope for a curative
outcome, the treatment regime for around 80 % [2] of the pa-
tients classified as severe stages only gears towards palliation [4].
An intra-arterial radiation approach, radioembolisation (RE) is ubi-
quitously applied as one of palliative approaches. Although, in
general RE shows promising results in intermediate and advanced
stage HCC [5], individual treatment outcomes are currently unpre-
dictable. Corresponding stratification criteria are still unclear.
We hypothesised that individual radioresistance/radiosensitivity may
play a crucial role in treatment response towards RE strongly influen-
cing individual outcomes. Further, HCC represents a highly heteroge-
neous group of patients which requires patient stratification
according to clear criteria for treatment algorithms to be applied in-
dividually. Multilevel diagnostic approach (MLDA) is considered help-
ful to set-up optimal predictive and prognostic biomarker panel for
individualised application of radioembolisation. Besides comprehen-
sive medical imaging, our MLDA includes non-invasive multi-omics
and sub-cellular imaging. Individual patient profiles are expected to
give a clue to targeting shifted molecular pathways, individual RE
susceptibility, treatment response. Hence, a dysregulation of the detoxi-
fication pathway (SOD2/Catalase) might indicate possible adverse
effects of RE, and highly increased systemic activities of matrix metallo-
proteinases indicate an enhanced tumour aggressiveness and provide
insights into molecular mechanisms/targets. Consequently, an op-
timal set-up of predictive and prognostic biomarker panels may
lead to the changed treatment paradigm from untargeted “treat
and wait” to the cost-effective predictive, preventive and perso-
nalised approach, improving the life quality and life expectancy
of HCC patients.
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Achieving and sustaining seamless “drug – companion diagnostic”
market access requires a sound strategy throughout a product life
cycle, which enables timely creation, substantiation and communica-
tion of value to key stakeholders [1, 2]. The study aims at under-
standing the root-cause of market access inefficiencies of companies
by gazing at the “Rx-CDx” co-development process through the
prism of “value”, and developing a perfect co-development scenario
based on the literature review and discussions with the subject mat-
ter experts. The presenter suggests that an integrated market access
approach is the need of the hour, and it should cover the entire “Rx-
CDx” value chain – from early-stage pre-clinical (Rx) and feasibility
(CDx) studies to post-launch considerations of a co-labeled product
[3]. Such approach can leverage patient selection strategies to re-
duce clinical study size, increase chances to achieve earlier regulatory
submission and launches, contribute to better upside for drug devel-
opers, simplify value justification, fit with the emerging “value-based”
healthcare delivery practices, enable risk sharing, and facilitate fund-
ing of the biomarker research [1, 3, 4].
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Objectives: The United Nations estimates in the past two decades di-
sasters have cost over 1.3 million lives and US $2 trillion damage.
During the first week following the 2010 Haiti earthquake, an esti-
mated 20,000 people died each day due to lack of surgical facilities
[1]. To improve survival, disaster response resources must be “on-
site” within 24 hours - not the days to weeks currently accepted [2].
Approaches: Trauma and stroke centers (TSCs) evolved when evi-
dence showed that immediate “24/7” treatment resulted in drama-
tically improved morbidity/mortality [3, 4]. TSCs are part of the
“mainstream” ongoing healthcare delivery and education system -
not a separate entity. All TSC physicians, nurses, and personnel (both
senior and in-training) are seamlessly integrated into the overall
healthcare system. Equipment is available (e.g. operating rooms and
battery-driven CTs, portable by helicopter) for a mobile trauma cen-
ter to be operational anywhere worldwide less than 24 hours after a
disaster strikes. Fortunately the universal humanitarian response to
disasters removes political, cultural, and socioeconomic barriers that
hinder the response to other global medical problems.
Results: Disaster response remains separate from ongoing healthcare
systems, e.g. UNOCHA (UN Office for Coordination of Humanitarian Af-
fairs) and the Red Cross. We propose that disaster response - like TSCs -
be integrated into ongoing healthcare systems worldwide (governmen-
tal/nongovernmental, national/international) [2]. This global “mega TSC
system” would improve disaster response and, moreover, establish
worldwide training, certification, and research standards for healthcare.
Recommendations: There are substantial political, cultural, and socio-
economic benefits - in addition to healthcare benefits - of integrating
disaster response globally into the ongoing healthcare system.
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Objectives: USA spends twice other developed countries on health-
care, yet lags far behind. Its near neighbor, Cuba, spends one-tenth
per capita compared to USA, yet matches or exceeds on life expect-
ancy and infant mortality [1]. Can USA healthcare merely rein in ex-
cessive costs (as healthcare economists assert), or is a fundamental
change necessary?
Approaches: USA healthcare embraces the profit incentive, and the
necessity for healthcare insurance. Despite its title, the Affordable
Care Act (ACA – aka “Obamacare”) has not reduced healthcare costs
[2]. The massive healthcare lobby in Washington DC and state capi-
tals – more than three times the defense lobby financially – ensures
that those parties doing well under the current system will continue
to do well. Opposition to the present system is met with “socialized
medicine”, a term commonly equated with “un-American”.
Results: Under ACA, costs shifted from insurer to patient: increasing
deductibles ($5,000/year or more) and co-pays (up to $75 per out-
patient visit) make it cheaper for US citizens to travel to Europe for
surgical procedures (paying cash!) than pay deductibles/co-pays in
the USA [1, 2]. A primary physician is reimbursed $16 for a patient
covered by Medi-Cal (the California coverage for the uninsured) – ¼
the co-pay under some insurance plans. Residents/registrars now
spend time learning “coding” – classification of medical care to
maximize hospital and physician reimbursement – rather than med-
ical science or patient care [1, 3]. The hospitalist model allows con-
venient “shift work” medicine, but degrades continuity – essential for
efficient healthcare. Economists manipulate statistics to demonstrate
incremental financial advantages of “tweaking” USA healthcare –
which fail more comprehensive analyses.
Recommendations: Despite the political and lobbyist inertia, USA phy-
sicians unanimously recommend universal healthcare (like all other
developed countries) [1, 4]. In education – lacking rich lobbyists -
“commercial” (for-profit) colleges have recently declared bankruptcy
(Corinthian Colleges) or been charged with stock-fraud (ITT Educational
Services). They profited from government-backed student loans but -
with meaningless diplomas - graduates remained unemployed, default-
ing on loans. A prime example of “profits are privatized, but losses are
socialized” – is also true in USA healthcare [1]. Until USA realizes that
for-profit healthcare cannot be “too big to fail or jail”, meaningful
healthcare reform will remain elusive. Learn from USA healthcare!
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Scientific Objective: Indoleamine 2,3 dioxygenase (IDO) is a cytosolic
enzyme and a major pathway for metabolism of tryptophan in a variety
of cells including immune cells. Increasing evidence indicates that IDO
is a critical player in establishing the balance between immunity and
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tolerance and ultimately maintenance of normal homeostasis. Gingivitis
is a prevalent human condition with the hallmark feature of severe in-
flammation but the role of IDO in this condition remains elusive. Thus,
this study tested the hypothesis that IDO is a pivotal player in regulat-
ing the immune and inflammatory responses of gingiva.
Technical Approach/Methods: We utilized the IDO knockout mouse
model in conjunction with lipopolysaccharide (LPS)-induced gingi-
vitis. Accordingly, wild type and IDO knockout mice were injected
with LPS in the anterior mandible followed by procurement of
gingival tissue for histopathology and preparation of tissue for flow
cytometry-based studies.
Results/Interpretation: Clinical and histological examinations re-
vealed marked adverse impact of IDO deficiency on LPS-induced gin-
givitis. These observations were consistent with a marked increase in
the pro-inflammatory cytokine interleukin (IL)-17 positive cells but no
significant change in the anti-inflammatory IL-10 positive cells. Con-
sistent with the more marked pro-inflammatory impact of IDO defi-
ciency, the percent of regulatory T cells (Tregs) was markedly lower
in gingival tissue of IDO knockout than wild type mice. These pro-
inflammatory changes were accompanied with marked increase in
apoptotic and necrotic cell death in gingival tissue of IDO knockout
than wild type mice.
Outlook/Expert recommendations: Severe inflammation of periodontal
soft tissue is a hallmark feature of gingivitis. If left untreated, it can
progress to destruction of alveolar bon, ultimately causing mobility
and loss of one or more teeth. Thus, effective treatment modalities
emanating from the pathogenesis of gingivitis as well as the possibil-
ity of predicting gingivitis lesions with greater propensity to progress
to periodontitis would be of clinical relevance and significance. Our
studies have established the role of IDO in pathogenesis of gingivitis
thereby laying down the foundation to further explore and harness
its predictive and treatment potentials for diseases of periodontal
tissues.
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Scientific objective: To verify via limited clinical trial the efficacy of
personalised nutrition proposed for the treatment of patients with
diabetes type 2 (DT2).
Technological approaches: 1) screening of patient-centred diets
based on detection of each person saliva and gut microbiome
profile (SGM) and on previous data obtained in vitro and in vivo
experiments about ability of plant originated foods and selected
fermented traditional products’ to regulate specifically the ratio
between commensal and opportunistic representatives of human
SGM; 2) limited clinical diet experiment for randomly assigned for
classical antidiabetic therapy and patients fed additionally with
person-selected local ethnical foods, with chemically analysed [1]
and balanced composition of biologically active compounds and
defined by MALDI and gene sequencing technique microbial
content.
Results interpretation: Specific SGM profile of each patient had been
indicated before and after applied diet. Implementation of control
diet led to the normalisation of the majority of SGM representatives.
Increasing number of Lactobacillus spp. was accompanied by re-
duced levels of glycosylated haemoglobin. Reduction of cholesterol
and triglycerides in the blood of patients had been correlated with
the decreased amount of Enterococcus spp. in gut microbiota con-
tent. Normalised glucose and improved ratio between low and high
density lipids had been reported.
Outlook and Expert recommendations: Chronic inflammation led to
the development of human metabolic non-communicable disorders.
Earlier we had proposed alarm markers for diagnostic of DT2 and
cardiovascular diseases [2].
This study recommends to develop software/in silico model in order
to apply widely obtained algorithm of personalised nutrition ap-
proach for patient-centred treatment for other chronic diseases con-
nected with human microbiome disbalance.
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Scientific objectives: In spite of a wide bibliography concerning
physiotherapy, there are still no comprehensive studies on the influ-
ence of patient’s age, gender, BMI, dose of therapeutic agent, treat-
ment’s duration and application’s order in the therapy outcomes.
Personalization of physical treatment is not a trivial task; it requires a
proper planning of procedures, especially in case of multiple therapies.
Monitoring of the changes due to various stimuli is essential for proper
planning. Thermal imaging enables the assessment of body reaction
and can be exploited in the physical medicine. The main objective of
our study is to compare the polytherapy results depending of the
order of administration as well as individual parameters. This
study was performed with the formal approval of the Senate
Committee for the Ethics of Scientific Research of the Wroclaw
University School of Physical Education.
Technological approaches: Thermographic recording was used to
estimate the thermal effects of the physical treatments. Various phys-
ical stimuli were applied, as electric current, ultrasound, thermal
agents and cryogenic cooling in various orders. The study was
conducted on the healthy volunteers. The influence of the multiple
therapies sequence, as well age and BMI of treated individuals was
evaluated.
All volunteers involved in the study fulfilled the inclusion criteria and
were informed about the risks and benefits of the procedures. Their
consent was obtained, and all participants were familiarized with the
study's purpose and procedures.
Results interpretation: Our observations revealed that age should be
taken as a premise to personalization of the treatment parameters.
The elderly persons usually react more exhaustive on physical stimuli
and this reaction lasts longer. Also the order of physical treatments
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in case of polytherapy is important and can cause significant
temperature changes in the treated area.
Outlook and Expert recommendations: Monitoring of the thermal
response to various physical agents may help to plan physical treat-
ments more precisely. The further studies are necessary to establish
the optimal therapies, parameters and sequences, depending on
the individual responses of the treated individuals.
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Scientific objectives: Human microbiome data and the natural way
of its correction needed to be exploited for implementation of
patient stratification strategy.
Verification of in vitro, in vivo, ex vivo, in silico models and detected
biomarkers of chronic diseases should be revised for realisation of
new health care-system based on innovative personalized manage-
ment of disease and health via creation of clinically and economically
optimal diagnostics/treatment algorithms.
Technological approaches: 1) in vitro (human dendritic cells derived
from peripheral blood monocytes, DCs), in vivo (mice/rats animal
models), ex vivo (fragment culture technique) and in silico (data bases of
limited cohort study) models for detection of strongly correlated
biomarkers of initiation of low-grade inflammation including changes
of saliva/gut microbiota (SGM) compositions, relevant molecular
pathways, metabolic production and typical epigenetic factors; 2)
integrated in vitro Simulator of Human Intestinal Microbial Ecosystem
(SHIME) technology platform for verification of efficacy of proposed
pre-screened natural ways of human microbiome correction and
biomarkers validation.
Results interpretation: Chronic low-grade inflammation is the key
linking factors of the metabolic and age relevant diseases. As results of
limited cohort studies indicators for early diagnostic of the selected
non-communicable diseases (obesity, diabetes type 2 and cardiovascu-
lar diseases) based on correlation between microbial, biochemical and
immune parameters are proposed.
Healthy products in form of modified ethnical foods were designed
and ability of their active components to effect on SGM, modulate
specifically host immune reactions and improve host lipid metabol-
ism were proved on DCs, mice/obese rats models and verified in lim-
ited diet clinical intervention study.
Outlook and Expert recommendations: 1). Direct coupling of the
SHIME technology with cell culture models required for evaluation of
the gut barrier and endothelial function;
2). Clinical intervention study with SGM sequencing data before and
after defined diets implementation for chronic diseases treatment is
necessary;
3). Comparison of SHIME integrated technology with results ob-
tained on cells/animal experiments and in silico model data for
evaluation of adequacy of pre-clinical and clinical tools for the fol-
lowing implementation of patient stratification strategy in health
care system.
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Outcome
Patients with chronic diseases should be able to perform a substantial
part of outpatient care by themselves if they are sufficiently supported
by new technologies. INTERACT-chronic aims to realise a platform for
chronic disease management that is evidence-based and patient-
centred, gradually shifting disease-specific, caregiver driven care to inte-
grated patient self-care.
INTERACT-chronic stands for Integrating e-health To Efficaciously
Raise the level of Contemporary Treatment in Chronic diseases. It is a
pan European consortium with broad experience in e-Health solu-
tions including university medical centres, knowledge institutes and
innovative companies including a US partner. The consortium is
seeking funding to reach its high ambition: the development of an
e-Health system that revolutionises chronic care.
Substantial change in delivering care urgently needed
Health care in Western countries requires an innovative approach to
provide sustainability of care and prevent the collapse of the current
systems. The increasing prevalence of chronic diseases combined
with their enormous economic impact and the increasing shortage
of health care providers are among the most critical threats. At-
tempts to solve these problems have failed and future limitations in
financial resources will result in much lower quality of care. Thus,
changing the approach to care for chronic diseases is of utmost so-
cial importance.
Patients in driver’s seat
INTERACT-chronic will achieve this ambitious aim by realising a
decision-support system enabling evidence-based self-management
by the patients. Poor interaction and communication between stake-
holders are major obstacles in delivering efficient and cost-effective
care. Therefore, we will also provide a platform for an optimal inter-
action and communication between patients, their relatives and care-
givers. This will facilitate patients’ self-management and enhance
cooperation between caregivers. A comprehensive ICT system will
support patients herein, focussing on care integration in complex pa-
tients. INTERACT-chronic will apply a holistic disease management
process for preventing, predicting, diagnosing and treating chronic
diseases, which will replace traditional, disease-specific care. INTERACT-
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chronic will build the ICT system upon a number of important pillars
that are innovative on its own, but unique in their combination.
Patient involvement in the whole chain
Patient involvement in every phase of the project including imple-
mentation into clinical practice is central. This precondition is com-
bined with the involvement of all other stakeholders who participate
in the management of chronic diseases to sufficiently address the
specific needs.
User-friendly devices
Very user-friendly front-end personal devices will enable patients, ir-
respective of age and education level, to adequately use the indivi-
dualised e-Health system, by applying novel engagement technology
to communicate with and educate the patients.
Integrated ICT system enabling improvements
An integrated communication and data platform for all involved
stakeholders will enable fast, easy and comprehensive exchange of
information and data between all involved, considering data privacy.
Central storage will allow further process and use of all data. This will
enable compatibility of patient data and central data processing
which is a crucial prerequisite for success. The possibility to further
adapt and improve the system will make the system flexible and able
to enhance its quality.
Decision support system
A central part of INTERACT-chronic is a decision support system that
compares individual patient data with available knowledge, based on
guidelines and existing patient data. The decision support system will
be built in a way that it is able to gradually increase the complexity
of advice communicated to patients for self-management. Appropri-
ate clinical testing will guarantee its reliability and accuracy.
Effective support in critical decisions
A novel, pioneering methodology to successfully evaluate the effi-
cacy of the system will make its progress much faster than it is pos-
sible with current approaches. It also allows decisions to be made
more flexible and to be handled at different levels through-out the
whole chain from disease prevention to palliative care. The latter
will support decisions to most efficaciously improve quality of life
and to prevent patients from being exposed to expensive, but use-
less treatment.
Huge social and financial impact
The a priori approach of multiple chronic diseases reflects the need
of patients much better than current care focusing on single diseases
and it is a prerequisite for broad implementation of true self-
management. This will result in benefits also for the society as a
whole as it uses available resources much more efficiently. Therefore,
the social and financial impacts will be huge. In a clinical study, we
will show that our approach is superior to current standards re-
garding prognosis, quality of life and patient satisfaction, at much
lower costs.
New market and value network
Thus, INTERACT-chronic aims to increase longevity of the patients
while reducing total costs significantly, which as yet has been consid-
ered impossible. Once established, our approach can be extended to
care in general. We aim to create a new market and value network,
and eventually disrupt existing care models to facilitate and motivate
patients to actively participate in both care and health. Taken to-
gether, INTERACT-chronic will address the whole chain of health and
care in patients with chronic diseases. This requires not only novel
and innovative technology, but also an innovative and novel vision
on care and health. This combination is exactly what makes INTERACT-
chronic so unique.
Further information:
• Hans-Peter Brunner-La Rocca, Professor of Cardiology / clinical heart
failure, Maastricht University Medical Centre, NL – T +31 43 3877097,
hp.brunnerlarocca@mumc.nl
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The big successes in cardiovascular medicine resulted in a rather un-
selected approach to treatment. Thus, treatment is often uniform for
all patients with a particular disease, as expressed in current guidelines.
Moreover, focus was and still is on treatment rather than prevention.
Still, PPPM plays an important role in cardiovascular medicine that
is often neglected. E.g., treatment of hypertension, hypercholesto-
laemia and diabetes mellitus actually is to prevent disease though
often rather late.
Important steps still must be made. Prevention should start earlier
and must be much more attractive since an unhealthy lifestyle obvi-
ously is currently more appealing to the majority of the population.
Current campaigns are not reaching the targets and foci should be
changed. E.g., interventions already during childhood are promising
(e.g. integration of exercise in school), but are not implemented due
to questionable reasons. Processed food which is healthy, but equally
attractive as junk food may help. Recognising risk earlier with more
specific interventions could have important impact for the general
population.
The efforts to predict risk at every stage from health (healthy popula-
tion) until advanced disease (e.g. advanced heart failure) unfortu-
nately have not resulted in targeted interventions due to several
reasons. Among others, predictive models are often retrospective
and not prospectively validated. Importantly, interventions based on
such models are often not prospectively tested. Thus, predicting risk
does not necessarily imply that the best intervention is known to im-
prove outcome, unless this has been specifically tested. This, how-
ever, is hardly the case.
The EPMA Journal 2016, Volume 7 Suppl 1 Page 5 of 42
Making this step would be important progress towards (more) perso-
nalised medicine in both preventing and treating cardiovascular dis-
eases. Several prerequisites are important to achieve the goal of real
personalised medicine. This includes detailed understanding of the
pathophysiology of cardiovascular diseases. Thus, it may be not suffi-
cient to know if a disease is present or a patient is at risk to develop
a disease, but to understand the different mechanisms causatively in-
volved in this disease. Very likely and also shown in some instances,
such further classification may allow to more specifically and more
efficaciously address this disease. Heart failure with preserved ejec-
tion fraction (HFpEF) is a good example for this. Moreover, likely not
all patients with a certain disease profit equally from the same inter-
vention. If not purely related to symptom reduction and several op-
tions are available, it is hardly known which intervention is most
important in individual patients and which even might cause harm. If
known, we could speak of real PPPM.
The question arises how we can reach this target. Among other,
more specific diagnostic testing/prediction are important and bio-
markers may be very helpful in this. Applying omics-approaches to
find target markers from a huge set of molecules has not yet resulted
in any clinically meaningful outcome, most likely because such an
approach requires an enormous amount of patient data to identify
targets which then have to be prospectively tested. On the short to
medium term, it might be more promising to investigate specific
targets that are already known or suggested to be pathophysio-
logically important, as the gap with clinical reality may be other-
wise too large.
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Introduction: The application of nanoparticles allowing the combin-
ation of therapy and diagnosis, known as theranostic, has received
increasing attention in biomedicine. Thus, nanoparticles of gold [1]
and cerium dioxide [2] were reported as strong agents against
oxidative damage having anti-aging activity. Nanoparticles of cerium
dioxide, considering its UV-shielding effect, antiviral, antibacterial,
antifungal activity, cardioprotective, neurotrophic, hepato- and
nephroprotective, and anti-aging effect, have potential for various
biomedical applications. Imaging is crucial for evaluation efficacy of
treatment, material distribution and personalized interventions. The
relevant visualization of solutions of nanoparticles on magnetic
resonance imaging (MRI) provides innovative perspectives to image-
guided treatment, drug delivery, development novel contrast media,
etc. for ensuring theranostic approach.
The aim was to evaluate the visualization of solutions of nanopar-
ticles with beneficial biological properties on magnetic resonance
imaging.
Methods: We performed three consecutive experiments, each included
ten mice, weight of 9 mice was 28-35 g and weight of one smaller
mouse was 14-17 g; all were injected with 200 mkl of the solutions as
follows:
1. saline, small mouse (14-17 g) - control;
2. saline, larger mouse (28-35 g) - control;
3. cerium dioxide nanoparticles orally;
4. cerium dioxide nanoparticles and gadolinium orally;
5. gadolinium orally;
6. cerium dioxide nanoparticles intraperitoneally;
7. cerium dioxide nanoparticles and gadolinium intraperitoneally;
8. gadolinium intraperitoneally;
9. gold nanoparticles intraperitoneally;
10. europium and cerium dioxide nanoparticles intraperitoneally.
All mice underwent magnetic resonance imaging in T1-WI VIBE iso
fat suppression, TR - 18, TE - 3.8, Flip angle - 10°, fat suppression -
SPAIR, resolution: FoV 190 mm (phase 100 %), slice thickness -
0.5 mm, base resolution - 256 mm, phase resolution -100 %, slice
resolution - 83 %.
Signal intensity was measured at 30 and 60 min after injection in
different organs and tissues three times and average value was
calculated.
Results: We obtained heterogenous data in all experiments, the high-
est signals were registered in kidneys of all mice. We revealed slightly
superior magnetic signal intensity in brain and muscles in mice
injected with gold nanoparticles and europium with cerium dioxide
nanoparticles intraperitoneally vs controls and vs mice injected with
gadolinium; data are presented on Table 1.
Conclusion: Nanoparticles demonstrated fair contrast effect on MRI
comparable with gadolinium.
Outlook and Expert recommendations: Preliminary results might be
promising in particular to use for brain tissues imaging / interven-
tions, considering penetrating EBB and combine application with ad-
vances of brain imaging modalities [3,4]. The follow up the study
promising to focus on physical properties of nanoparticles, including
sonoporation, photoacoustic imaging, ultraviolet spectra, paramag-
netic properties, etc.; a study on interactions with other nanomater-
ials and combination with other biological (gene, regenerative)
therapies.
It is recommended to create an international project to study nano-
particles application in diagnosis and therapy of neurodegenerative,
heart, liver, and kidney diseases and muscle dystrophy, combining
with biological therapies to achieve sustainable effects from thera-
nostic approach.
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1 2 3 4 5 6 7 8 9 10
muscle 520 577 560 557 590 598 555 500 552 670
liver n/a 537 512 554 626 514 590 541 545 590
kidneys n/a 706 630 666 642 622 590 627 n/a 646
brain 530 n/a 510 496 484 566 558 557 556 530
heart n/a 504 512 577 549 444 566 481 507 460
* number corresponds to the injected substance, as in Methods paragraph
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Introduction: The diagnostic ultrasound (US) is used for peripheral
nerves visualization, particularly in regional anesthesia; recently we
formulated diagnostic markers of peripheral neuropathy, based on
ultrasound of nerve structure changes [1]. The US characteristics for
peripheral neuropathy diagnosis in patients with diabetes mellitus
(DM), in particular by distinguishing types 1 and 2 are not studied yet.
PainDETECT is an effective screening questionnaire to identify neuro-
pathic components in patients with back pain [2].
The aim of paper was to study the nerve structure changes in
patients with diabetes mellitus type 1 and 2.
Materials and Methods: We included 30 patients of both genders,
assessed into the following two groups: 1 (n = 15) - DM type 1 (16-32
years old); group 2 (n = 15) - DM type 2 (48-63 years old) with period
of disease 1-5 years, suffering from clinically diagnosed neuropathy
of lower limbs. Deference in age bias was unavoidable due to differ-
ence in age of first manifestation and development of DM I and DM
II, but period of disease was similar. As a control group we included
20 volunteers (18-54 years) without clinical disturbance of periph-
eral nerves.
We conducted survey using linear 12 MHz ultrasound probe per-
forming scanning at the lower femoral level from posterior access.
We measured fascicular diameter, nerve cross-section area [1].
Patients underwent a standardized nerve motor and sensitive nerve
conduction study and responded PainDetect questionnaire (1-38)
scores [2].
Results: In patients of the first group the ultrasound symptoms of
nerve structure disorder were revealed: the changes of nerve cross-
sectional area were insignificant among groups (P >0.05); swelling of
the nerve bundles; fascicular diameter was 1.8 mm in first group
(p < 0.01), and 1.1 mm in second and 0.9 in control group (in 83 %
patients). Indirect US signs of neuropathy are registered as follows:
reducing number of nerve bundles, increase in the fibrous compo-
nent, inequality nerve path, thinning of the muscles and reducing
the amplitude of movements.
Conclusion: Ultrasonography is an effective diagnostic tool for dia-
betic neuropathy, in particular for early diagnosis in patients with
DM type 1 in young age.
Outlook and Expert recommendations: According to obtained re-
sults, ultrasonography has strong diagnostic predictive potential for
neuropathy, much expressed in patients with DM type 1. Further
studies for correlation imaging–neurophysiological molecular data
and validation are needed.
Current diagnostic imaging information should impact on the diag-
nostic thinking of the clinician, effect on the patient management
plan, improving the therapeutic outcome and have essential societal
benefits of implementing this diagnostic imaging technology. It is
recommended to initiate screening program for diabetic patients
with DM type 1 for early diagnosis, patient stratification and
preventive measures in young age, and to organize relevant educa-
tional programs.
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Introduction: The “diabetic foot” is a group of syndromes in which
neuropathy, ischemia, and infection lead to tissue breakdown. Approxi-
mately 60 % of all diabetic foot ulcers (DFU) result from neuropathy;
of these, half are related to peripheral arterial disease [1]. Complications
of DFUs, such as infections and gangrene, frequently lead to
hospitalization and to extensive tissue destruction or amputation and
impaired quality of life, incur a significant cost economically, socially
and psychologically [2,3]. Even when ulcers are healed, >50 % will have
a recurrence after 3 years [2]. Neuropathic ulcers, deep foot infection,
site of ulcer (plantar for foot ulcer, metatarsal head) and co-morbidity
(non-retinal eye disease, end-stage renal disease, edema, walking
disability) are related to minor or major amputation in non-ischemic
patients. Edema is usually of multifactorial origin, is related to outcome
both in neuropathic and neuro-ischemic ulcers, and should be treated
accordingly. Diabetes with neuropathy and a long-standing plantar
ulcer increases the risk of infection and an infected foot ulcer precedes
about two thirds of amputations [4]. Stratification of DFU according
neuropathic; ischemic and congestive mechanism is crucial for preven-
tion of ulceration and personalized treatment [5].
The Aim was to evaluate ultrasound signs for stratification DFU
according neuropathic; ischemic and congestive mechanism and
personalized preliminary evaluate treatment efficacy of nanoceria.
Materials: We included 14 patients (9 males, 5 females, age was 52-
73 years) with diabetic foot ulcers (DFU). Ultrasound survey was
conducted using 12-18 MHz probes of GE Logic equipment. There
were no signs of osteomyelitis on Ro. All were treated according to
the standards including insulin therapy, gauze with hypertonic
solution (0.45 % NaCl) in the wound channel; antibiotic therapy
(lincomycin intramuscular on course for 7 days); daily dressings.
Results: We revealed dominating of several ultrasound patterns as
follows:
In neuropathic pattern (n = 9) ultrasound finding demonstrated signs
of diabetic neuropathy of lower limb nerves– we defined thickening
fascicles of nerves to 2-4 mm (while normally to 1-2 mm) with
pronounced inter-fascicular fibrosis with normal arterial and venous
blood flow. During all cases in the phase of wound healing we
observed granulations with intensive local vascularization - positive
predictive sign. In patients with gout we found uric acids deposits
inside the joints and in granulation tissue in scars that slowed down
the healing. A small amount of liquid content might be considered
as wound exudates or an inflammation.
In ischemic pattern (n = 6) the typical presentation of reduced
blood flow and multiple arteries occlusions and strongly declines
peripheral circulation, no swelling and nerve changes were
revealed.
In congestive pattern (n = 3) we revealed extensive vein conges-
tion, soft tissues edema and joints effusions, accompanied with
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lymphadenopathy, lymphostasis, and deep veins thrombosis. Arterial
blood flow and nerves structure remained relatively unchanged. We re-
vealed bone surface deformations with small ulcerations.
Personalized treatment approaches
Recently Chigurupati et al. reported that topical application of water
soluble cerium oxide nanoparticles (Nanoceria) accelerates the heal-
ing of full-thickness dermal wounds in mice by a mechanism that in-
volves enhancement of the proliferation and migration of fibroblasts,
keratinocytes and VECs. The nanoceria can penetrate into the wound
tissue and reduced oxidative damage to cellular membranes and
proteins, suggesting a therapeutic potential for topical treatment of
wounds with antioxidant nanoparticles [7].
In three patients after ineffective standard treatment we performed
dermotropic ointment based on cerium dioxide nanoparticles in the
wound channel 2 times daily (in the morning and evening time).
After treatment we observed fast decreasing of ulcer total healing in
all patients. On ultrasound we observed intensive vascularization,
tissue regeneration signs.
After successful treatment of previous DFU two patients were re-
hospitalized on with recidivism and underwent the same treatment
strategy with positive outcome.
Conclusions: Ultrasound is effective for stratification DFU according
neuropathic; ischemic and congestive mechanism. Local application
of cerium dioxide nanoparticles weas efrfective for DFU wound
healing.
Outlook and Expert recommendations: Since preliminary results
provide good perspectives for use of nanoceria for DFU treatment we
suggest to create an international research project to study the
biomedical effects of nanoceria offer the prospect of its use as a UV
protectant, a drug with antiviral, antibacterial and antifungal activity, as
well as means capable of reducing the level of oxidative stress in
diverse tissues of human body. The larger studies with long term
assessment are required. Study of effects of nanoceria on vasospasm is
necessary for stratifications of potential responders to formulate clear
personalized application.
Considering biosafety of ceria nanoparticles, the group of potential
patients (consumers) of person-related smart physiologic low-dose
treatments can be large.
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Project ImaGenX is an Italia-Malta EU project between six partners
which seeks to strengthen breast cancer surveillance in both countries,
while also identifying genetic and environmental or lifestyle risks that
could affect breast cancer. The environmental and lifestyle risks ques-
tionnaire was designed by the University of Malta together with Pa-
lermo University, and has been carried out in Malta, Palermo and
Siracusa in an attempt to see which factors might influence the risk of
developing cancer. This retrospective case-control study focuses on
risks at the workplace (exposure), diet and lifestyle, based on available
literature on the subject, and is mostly exploratory in nature.
In Malta, over 600 participants were randomly selected and contacted
(200 cases and 400 controls), with cases being women with breast can-
cer without a family history – so-called “sporadic” cases and controls
being women who have not had breast cancer. Interviews were carried
out face-to-face, and participation was entirely voluntary. This presenta-
tion will focus on the methodology and challenges of this study, its lim-
itations, its possible data outcomes and possible ramifications of this
study within local public health scenario.
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Genomics is one of the most important unit of predictive, preventive
and personalized medicine (PPPM). All diseases of human body start in
molecular level and one of the main pathological pathways include
genes destruction. All diseases can manifest in any time of human life
or hide in another disease. In our time, we have a big permissions to
diagnose this molecular and genes destruction. Nowadays in scientific
article we can noticed a huge splash of attention to genetic tests and
way of diagnosis genetic diseases. Day by day, we come to the most
accurate and the most informational result of genetic test, but we have
some problems with it. The first - its money and the second - we do
not have enough qualified employees. We can solve problem with
qualified employees. In last EPMA congress, our group developed a
project about special medical education. The creations and develop-
ments of the special elective course at school helps students to get
acquainted with broad spectrum directions of PPPM and they must
have a clinical practice or take part in research in the structure of PPPM.
Students must take the knowledge about PPPM, when they study at
school. Now we have the first results of our work. In this day, we have
special scientific group, which include students at school, medical stu-
dents in university and medical professors in university. This system of
scientific work helps student at school take knowledge from medical
student, but also can help for them take a part in scientific work. As a
result, the work we can say that next year our group will release Med-
ical English-Russian dictionary. It will be the biggest and the fullest dic-
tionary about medicine. It will consist of new spheres of medicine such
as PPPM, genomics, metabolomics, microbiology and so one. And the
main idea that in work on this dictionary were included our school stu-
dents and they did a big part of this dictionary. We can give the name
of our system, for example, “From young professional to mentor”.
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Scientific objectives: Numerous questionnaires are used e.g. for
study therapeutic efficiency in miscellaneous medical fields. Recently,
the quality of life, not only the therapeutic responses, is in focus of
many studies. It is recognized that the quality of life is dependent on
specific parameters: the person's physical health, psychological state,
level of independence, social relationships, and their relationship to
salient features of their environment. Various questionnaires are used
for this purpose. The objective of this study is to statistically evaluate
the questionnaires adopted in various medical fields to measure the
quality of life.
Technological approaches: The published papers, majority of them
recorded in PubMed, were the primary sources of the information.
The following fields were taken into account: cardiology, rheumatol-
ogy, neurology, gastrology, transplantology, diabetes, oncology,
gynecology, dermatology, dietetics and sport science.
Results interpretation: The most frequently used questionnaires are:
The Medical Outcomes Study 36-Items Short – Form Health Survey
(SF-36), The Short Form 12 (SF-12), The Six-Dimensional Health State
Classification Short Form 6D (SF-6D), Euro-Quality of Life Question-
naire (EQ-5D), and The World Health Organization Quality of Life –
BREF (WHOQOL-BREF).
Our analysis shows that SF-36 was employed most frequently and
ranged between 60 % and 100 % in all of the 130 papers that were
evaluated. At 20–50 %, the second most frequently employed
questionnaire was EQ-5D. Overall, scientific development shows that
there is an increasing number of studies on the quality of life. As and
example until 1995, 512 questionnaire studies on the quality of life
were recorded in the PubMed database, were us until 2014, this figure
rose to 6325.
Outlook and Expert recommendations: As a result of the growing
interest on the quality of life and the quite inexpensive data collec-
tion that requires little effort, a further rise in the number of studies
on the quality of life using questionnaires can be expected. Contem-
porary medical science is concentrated not only on diagnosis and
treatment and the improving the general quality of life is important,
as well. Predictive, preventive and personalized approach should
consider the life quality assessment.
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Muscular dystrophies (MD) are representing a clinical and genetically
heterogeneous group of severe progressive disorders often fatally
leading to death. Despite recent advances, unfortunately in about
50 % of the patients disease genes are unknown. Currently, there are
no curative treatments available for muscular dystrophies. There is
a disease ameliorating therapy in development for the common
form Duchenne Muscular Dystrophy based on Exon skipping ther-
apy [1, 2]. A major obstacle for translational research is unfortu-
nately that for many MD forms even the underlying disease genes
and mechanisms are unknown. There is an unmet medical need for
an integrated systems approach to understand the genetic, bio-
chemical and pathophysiological basis of MD for the development
of personalized medicine.
By whole exome sequencing, we have discovered 3 new genes (ISPD,
B3GALNT2 and GMPPB). The biochemical function of isoprenoid synthase
domain containing (ISPD) in mammals remain unknown. Remarkably,
we identified a novel CMD phenotype harbouring mutations in ISPD
characterized by LGMD, oculomotor apraxia, myopia and cerebellar hy-
poplasia. Further Genotype-Phenotype correlations of muscular dystro-
phies are investigated using combined next generation sequencing
approaches from >200 cases will be shown.
To explore the possible effects of missense mutations ISPD, we have
mapped them onto the homology model of human ISPD derived
from the structure of a related bacterial protein (CDP-ME synthase;
1VPA). We have expressed recombinant His-tagged wt and mut. ISPD
protein in E.coli and purified Co-IMAC affinity chromatography. By
the use of Thermofluor we could confirm the differences in the stability
between wt and mut. ISPD proteins. We using Thermofluor for screen-
ing of chemical chaperones in order to develop personalized drugs.
To enable clinical trials, we performed a pilot study for the discovery of
serum biomarkers in LGMD2I and could identify various candidates,
which we grouped into a) myofibrillar proteins b) glycolytic enzymes, c)
extracellular matrix and d) other muscle specific proteins.
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Scientific objectives: ALK translocation is present in about 5 % of ad-
vanced NSCLC and is a predictive factor of response to ALK Tyrosine
Kinase Inhibitors (TKI), such as crizotinib [1]. Unfortunately, disease
progression occurs after a median period of 9-10 months of treat-
ment with crizotinib. Several mechanisms of resistance have been
identified and include other mutations in ALK gene, ALK amplifica-
tion, activation of bypassing signaling pathways involving EGFR,
KRAS and c-KIT [2]. Second-generation ALK-TKIs demonstrated an en-
hanced spectrum of activity in crizotinib-resistant ALK mutants. How-
ever, re-biopsy in NSCLC patients represents a critical issue and
analysis of circulating cell-free DNA (cftDNA) has a promising role for
identification of mechanisms of resistance to targeted therapy.
Technological approaches: Twelve crizotinib treated patients were
enrolled. After tumor progression, blood was collected and plasma
isolated by centrifugation. DNA was extracted from plasma using
QIAamp circulating nucleic acid kit (Qiagen®) and tested for ALK sec-
ondary mutations, KRAS exon 12 mutations and BRAF V600E, using a
Digital Droplet PCR (BioRad®).
Results interpretation: Eleven patients received crizotinib and only 1
ceritinib. ALK-TKIs was administered mainly as second-line, in 2 cases
as first-line and in the remaining as third-line therapy. Best response
was partial in 10 patients and stable disease in 2. Median PFS was
16.9 months. ALK secondary point mutations were identified in 3 pa-
tients, all female, never-smokers and treated with crizotinib. The first
showed p.L1196M and p.G1269A ALK mutations; their plasma levels
decreased after the 2 months of therapy with second generation ALK-
TKI, in association to tumor response. The second presented p.L1196M
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while the third, initially wild-type, showed p.F1174L after initiation of
second generation ALK-TKI. In a total of 9 patients, including those with
secondary ALK point mutations, the KRAS mutation G12D or G12V ap-
peared in blood samples at the time of resistance to TKI.
Outlook and Expert recommendations: ddPCR can detect resistance
mutations in cftDNA of ALK+ NSCLC and may represent an effective
alternative to re-biopsy. Moreover, the assessment of mutated allele
burden could be used for response monitoring during treatment.
Moreover, the development of KRAS mutations may play a role in re-
sistance to ALK-TKIs.
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Background: Domestic animals, such as dogs, cats and horses develop
IgE-mediated allergies comparably to humans (1). Common symptoms
include chronic pruritus, papules, erythema, sometimes urticarial lesions
and, in cats and horses, asthma. The most prominent clinical pheno-
type is canine, feline or equine atopic dermatitis (AD) elicited by re-
spiratory (2), food or insect venom allergens. In humans, component
resolved diagnosis of allergy using antibodies for IgE detection has re-
cently entered clinical routine. In cats, dogs and horses allergy diagno-
sis is so far performed with allergen extracts, but recently the usage of
the human alpha chain of the high affinity IgE receptor (FcεRIα) is im-
plemented for IgE detection in veterinary diagnosis (3, 4). The high in-
terspecies amino acid homology (54-56 %) is responsible for binding of
human FcεRIα with IgE of these species. We hypothesized, however,
that the IgE detection could be improved by the use of recombinant
species-specific FcεRIα in allergic dogs, cats and horses.
Methods: Canine, feline and equine recombinant FcεRIα (rFcεRIα) were
expressed in CHO- DUKX B11 cells using a custom SV40_Neo mamma-
lian expression vector. 384 clones of each species were evaluated
for their production of IgE-binding rFcεRIα by immunoblotting and
Enzyme-Linked Immunosorbent Assay (ELISA) prior to isolation of
rFcεRIα from selected clones via anti-FLAG M2 affinity purification.
Results: Proper structure of rFcεRIα proteins was confirmed by CD-
spectroscopy. Immunoblot and ELISA experiments verified that the
three rFcεRIα proteins were able to bind IgE for the respective
species with high affinity to serum IgE of each species. Next, the IgE
binding capacities of the recombinant alpha chains will be compared
in solid phase assays.
Conclusion: The detection of serum IgE of veterinary patients by the ap-
plication of the three species-specific rFcεRIα may offer further tools for
improved allergy diagnosis in allergic veterinary patients in the future.
Sources of funding: The study was supported by the Austrian Sci-
ence Fund (FWF) grants SFB F4606-B19, W 1248-B13 (MCCA), and in
part by P23398-B11 and W1205-B09 (CCHD).
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The nervous system of children is especially vulnerable to chemical
exposure because of a long developmental period beginning shortly
after conception and continuing through adolescence. The complex
developmental process requires precise coordination of cell growth,
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migration and network formation. Brain development can be
disrupted by even short-term exposures to chemical agents during
critical periods of maturation (i.e., fetal, neonatal and adolescence).
This disruption can lead to permanent functional deficits and may
predispose to disease later in life. Epidemiological studies suggest an
increasing incidence of mental and neurological disorders among
children and adults, including autism, attention-deficit hyperactivity
disorder and neurodegenerative diseases such as Alzheimer disease.
Environmental chemical mixtures, especially when exposures occur
early in life, are suspected to contribute to the etiologies of these
disorders. Developmental neurotoxicants are among the top 50
compounds listed by ATSDR they include: heavy metals (lead, meth-
ylmercury, cadmium…), polychlorinated biphenyls (PCBs), polycyclic
aromatic hydrocarbons (PAHs), polybrominated diphenyl ethers
(PBDEs) and organochlorine pesticides, namely dichlorodiphenyltri-
chloroethane (DDT) and hexachlorocyclohexane (HCH). According
to the European Commission, there are 143,000 registered chemi-
cals, many which have not been evaluated for possible neuro-
toxic properties, let alone their effect on the developing human
brain.
In this conference, a global methodology using in vivo, ex vivo and
in vitro tests as predictive markers for the screening of neurotoxic
potential of chemical contaminants will be presented.
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The actuality: It was found that the mechanisms of pressure
increase are largely dependent on age [1, 2]. In particular, it is
assumed that in the development of arterial hypertension (AH) in
young contingent significant role is played by the various
psychogenic factors [3, 4]. However, such studies carried out are
not enough.
Objective: Identification of personality profiles for young people
including self-centeredness, stress stability, anxiety-depressive disor-
ders (ADD) and features of stress reactivity.
Material and Methods: 147 young men aged from 18 till 25 years
were examined. Three groups were created: 1 – normal blood pres-
sure (BP) (n = 81); 2 – high normal BP, i.e. prehypertension (PH)
(n = 30); 3 – AH (n = 36). For assessment of psychological status the
hospital scale of alarm and depression (HADS), questionnaire of
stress-resistance and drawing test were used. Last test revealed the
various personal qualities of the subject, including creativity,
self-esteem, self-centeredness and others. At height of test "The
Mathematical Scoring" and in restoration assessment of haemo-
dynamic signs were carried out. Statistical processing was carried
out by means of the program BioStat.
Results: The tendency of reduction of stress-resistance in groups
with increased BP is revealed. The lowered stress-resistance was
observed for a third of young men with PH, practically a half of
ones with AH and only 16 % of persons with normal BP. A third of
young men with PH and a half of young people with AH alarm
signs came to light. ADD subclinical is revealed in 12 % and 5 % of
persons from the second and third groups of observation. The
most significant reaction BP and rhythm in response to stress-test
is noted at persons with signs of AH and PH. In individuals from
groups of increase BP were significantly more marked with pres-
ence of high self-esteem and the desire to achieve high scores of
people around.
Conclusion: Young people with existence not only AH, but also PH
should be carrying out stress-resistance and psychoemotional tests. It
is necessary to involve psychotherapist in preventive maintaining in
centers of student health [5] for more personalized prevention pro-
grams among young people.
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The actuality: Now psycho-emotional stress (PES) is one of the lead-
ing risk factors of cardiovascular (CV) diseases, including arterial
hypertension (AH) [1]. According to the international multicenter
study INTERHEART (2004) PES is among the leading factors of CV risk,
ranking third after smoking and dyslipidemia [2]. One variety of
chronic PES is job stress (JS) [3], which is far more studied in the field
of industry, transport [4], and much less studied in terms of law
enforcement [5].
Objective: Estimation the features of circadian blood pressure (BP) pro-
file in young men employed in the stress-associated field work of law
enforcement.
Material and methods: A total of 132 young men, exposed to different
severity of JS in type of operational activity (OA) of experience for 1 to
5 years were surveyed. Control group was formed of persons, whose
daily work is not related with OA. Circadian monitoring (CM) BP was
conducted on different days of the week, comparing results of the office
and DMBP determining.
Results: It was revealed that the presence of different forms of
stress-induced AH - stable, isolated office and hidden ones were
significantly more often compared to the control group. The most
significant violations identified by the time indices of increasing BP
day and night, as well as the speed of morning rise BP. In output
day, violations of DMBP leveled, that confirms the stressful nature of
diagnosed AH.
Conclusion: It is proposed the use of CMBP during regular medical
examinations of young men, exposed to the JS, in order to carry out
differential diagnosis of various forms of stressful AH in a good time.
This can be useful for the further conduct of individualized preven-
tion programs [1] in the workplace.
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The actuality: The phenomenon of augmentation, that has important
prognostic value [1], is studied basically on old contingent [2, 3]. At
young it is investigated much worse [4].
Objective: Estimation central aortic pressure (CAP), index of augmen-
tation (AIxао) and index of amplification (PPA) in young people,
taking into account the presence of RF.
Material and Methods: 78 students were surveyed within the
framework of the regular medical inspections on the basis of the
University Center of Student's Health. Screenings included: RF -
overweight, smoking, physical inactivity, anxiety/depression (A/D),
infectious-inflammatory diseases (IID) most often in the form of
pathology of LOR-organs, adverse heredity (AH), and arterial
hypertension (AH). Parameters were studied CAP by diagnostic
complex BPLab ('Peter Telegin', Russia). We provided systolic
blood pressure (BP) aortic (SYSао), diastolic BP aortic (DIAао),
index of augmentation in aorta (AIxао), pulse pressure amplifica-
tion (PPA) and others. There were two groups: 1 g. – RF not
present (control group); 2 g. - RF present (the basic group). Statis-
tical processing was performed by means of package of programs
«Statistica 8».
Results: Youth AIxao index in the two groups of observation was -8
(-12; 2 %) and -4 (-9; 2)% (p = 0.32), while among women the figure
was 1.5 (-2, 5; 5) and 7 (2.5; 12)% (p = 0.04). Among young men in
two groups PPA index was 148 (142; 158) % and 148 (137; 152) %
(p = 0.79), while among women the figure was 140.5 (133; 152) and
140.5 (132; 145) % (p = 0.89).
Conclusion: Under the influence of the FR in young people there is
an increase in AIxао. PPA remains almost unchanged. It identified
gender-specific violations of the AIxао. Girls are characterized by
increase of this index: almost six-fold, and the young men - only
twice. These data should be considered when implementing the
diagnostic screening of threats to cardiovascular health in young
people [5], as well as in the process of monitoring the effectiveness
of preventive measures among youth.
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Breast cancer burden
Breast cancer (BC) is the most common cancer amongst women
worldwide: annually about half a million deaths is reported [1]. First-
line screening program is through mammography for which false-
negative results, over-diagnosis and health adverse effects are not
rare issues. Although treatment approaches consider the known BC
relevant biomarkers (such as BRCA1/2, ER/PR, HER2, UPA, PAI-1, etc.),
a large number of BC cases remains unrecognisable for currently ap-
plied screening programmes, early detection, correct diagnosis and
prognosis, optimal treatment regiments such as triple-negative BC
patients with overall poor outcomes.
Cost-effective approach
Well acknowledged modifiable risk factor in BC are: diet, physical ac-
tivity, sleep quality, alcohol intake and psychological distress. The
proposed cost-effective approach might be the paradigm shift from
delayed to predictive, preventive and personalised BC management,
which considers shifting focus from illness to health, innovative
screening programs, regular monitoring of pre-disposed individuals
and the ones a high risk, targeted preventive measures and treat-
ments tailored to the individual.
PPPM in BC management can be effectively implemented by target-
ing the overall diagnostic and treatment approaches to well stratified
patient groups.
Patient stratification in BC management: creation of highly specific
and sensitive biomarker-panels
An optimal BC management considers the development of multilevel
diagnostics and treatment regiments:
1. Innovative screening programs identifying individuals at risk and
early-stage patients;
2. Stratification of BC patients predisposed to metastatic disease;
3. Creation of individualised patient profiles using specific biomarker sets;
4. Targeted preventive measures and treatment algorithms according
to the individualised patient profiles;
5. Prognosis of the disease severity and treatment outcomes.
Any stage of the above consolidate approach requires highly specific
and sensitive biomarker-panels to be created using medical imaging,
in-silico diagnosis and bioinformatics. Innovative concepts and non-
invasive blood tests are proposed [2-4].
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Detailed autopsy findings demonstrate that the absolute majority of
people are carriers of hardly detectable micro and asymptomatic
tumour lesions which, however, not necessarily may progress into
clinically manifested disease. Further, in case of manifested oncologic
diseases, less than 1 % of all disseminated and circulated tumour
cells have a potential to form secondary and distanced tumours
(metastatic diseases) – the phenomenon known as the “metastatic
inefficiency” [1]. In this context, the key question puzzling modern
predictive preventive and personalised medicine is how to discrimin-
ate between those carriers who are predisposed to a disease mani-
festation / progression and “silent” carriers.
By evidence, both initial tumours and secondary metastases need a
“fertile” microenvironment effectively supporting their growth and pro-
gression [2]. What are the mechanisms “fertilising” the microenviron-
ment for a particularly effective cancer advancement? In general, these
are local and systemic effects at molecular, cellular and tissue levels
which create hospitable conditions for tumour and metastatic colonisa-
tion. Amongst pronounced risk factors hypoxia is recognised as a
strong driver of aggressive cancer types and active metastatic disease,
e.g. triple negative breast cancer. Systemic hypoxic effects have been
demonstrated as forming pre-metastatic niches in distant organs [2,3].
Regarding specific phenotypes particularly predisposed to local and
systemic hypoxic effects, individuals with Flammer Syndrome (FS)
phenotype create prominent cohorts of healthy individuals in sub-
optimal health condition [4] as well as patients suffering from severe
diseases such as eye disorders [5,6]. In the above introduced context,
FS individuals are of particular interest, due to
– clearly defined phenotype [4]
– onset of symptoms early in life (puberty)
– more frequent in young women
– systemic hypoxic/ischaemic effects
– involvement of systemic molecular events (altered stress
response, multi-drug resistance and energy metabolism; shifted
regulation of transcription, apoptosis and adhesion; deficits in
DNA-repair efficacy; blood-brain-barrier-breakdown; extensive
tissue remodelling accompanied by highly increased activity of
the core of metalloproteinase) into pathogenesis of severe
disorders in patients with FS phenotype [7, 8]. All these
pathways are considered as evidently involved into effective
cancer advancement [9].
Our multi-centred study has been designed to respond to the follow-
ing questions:
1. Are women with FS phenotype more predisposed to cancer onset
and progression compared to the general population?
2. Are women with FS phenotype more predisposed to breast cancer?
3. Which types of breast cancer are more frequent in women with FS
phenotype?
4. Has FS phenotype a power to predict pre-metastatic niches in
cancer patients?
5. Is patients’ stratification in cancer and metastatic disease possible
by phenotyping with FS symptoms?
6. Is cancer prediction and prevention possible by FS phenotyping in
predisposed individuals?
Our multi-centred consortium will, further, report on the results
coming from this exciting study. A series of research articles is
currently in preparation by the EPMA nominated working group.
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EU birth rates in the global context
In the world ranking for annual birth rates (from place 1 for Nigel till
place 224 for Monaco with 46.12 versus 6.72 annual births, respectively),
all the EU countries are positioned very low beginning with the highest
rank 132 for Ireland (15.18 births/1000) and going deep into the lowest
rank for 219 for Germany – position 6th from the last place [1].
Improving healthcare for and increasing life quality of pregnant
women in EU
From the above statistical data it is evident that the birth rates in the
EU belong to the lowest ones worldwide. This fact motivates European
Union for improving the healthcare for and increasing life quality of
pregnant women, advancing the level of professional monitoring of
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pregnancy and delivery, and promoting the philosophy of predictive
and preventive medical services and wellbeing in pregnancy with im-
proved individual outcomes of delivery that is the main focus of our
consortium.
Epidemiology of prenatal / perinatal complications and “down-
stream” pathologies
Current statistical data considering worldwide epidemiology of pre-
natal and perinatal complications and pathologies have not been sys-
tematically analysed being frequently controversial for single countries.
However, recent studies have demonstrated the prenatal and perinatal
morbidity comprising the majority of the infant deaths giving a
general idea of the biggest impact of prenatal and perinatal com-
plications and reflecting extensive deficits in medical care as cur-
rently conducted to pregnant women. Further, for life births, when
newborns were affected by prenatal / perinatal complications,
individual outcomes are hardly estimable but the long-term conse-
quences might be dramatic such as hypoxic-ischaemic encephalopathy,
injuries of the central nervous system, epilepsy, strong predisposition
to develop neurodegenerative and cardiovascular diseases, diabetes
and cancer early in life [2-4].
Economical burden to healthcare systems
Already now the economical burden to healthcare systems is enormous
for each of the above listed pathologies with a very pessimistic progno-
sis for the next decade in case of less improvement in medical services.
Therefore, the quality of prenatal care is the central issue for entire pro-
gress in healthcare systems and economy to be made [5].
In the European and in high-income countries generally, the most of
the severe complications during pregnancy still occur in a-priori low-
risk pregnant women [6]. Consequently, the prioritised need is to
develop affordable instruments to diagnose and monitor most im-
portant risk factors in order to prevent development of high blood-
pressure, foetal growth restriction, preterm delivery leading to stillbirth
or neonatal death. Our consortium is open for international multi-
disciplinary collaborations which might create a series of projects re-
quired for effective advancements in the field.
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Introduction: Endometriosis is among leading gynecological patholo-
gies, amine precursor uptake and decarboxylation (APUD) cells still
were not sufficiently studied in this matter.
The aims were to conduct immunohistochemical assessment of
diffuse endocrine system (APUD) cells in uterus endometriosis
(adenomyosis) and ovarian endometriosis.
Materials and Methods: We included 25 patients with uterine
endometriosis (mean age 44.2 ± 1.67), and 19 patients with ovarian
endometriosis (39.4 ± 1,82 years old). The control group included 15
women (38.6 ± 1.54 years old) with no gynecological pathology.
Fragments of the myometrium with endometriosis, endometrioid
ovarian cysts walls, endometrium samples were assessed using
immunohistochemical study (murine monoclonal antibody sero-
tonin Ab-1, ClonDesignation 5HT-H20S). As the imaging system
we used UltraVisionQuantoDetectionSystemHRPDAB (Thermoscien-
tific). APUD cells were counted in 10 fields at average magnification
x280.
Results: The APUD cells were found in 18 patients in the adenomyosis
and in 16 patients with ovarian endometrioid cysts. In all patients APUD
cells were also found in the endometrium. In the control group few
APUD cells were observed in the endometrium (4-6 in 10 fields of view,
x280). In the endometrium of patients with adenomyosis we found 5.6
APUD cells in 10 views; in the endometrium of patients with endome-
trioid cysts - 22.4 ± 1.68, significantly increased vs the control group
(p <0.01) and vs group of adenomyosis patients (p <0.01). In the
endometrioid ovarian cysts walls we defined 28.6 ± 1.72 APUD cells,
significantly higher than in the foci of adenomyosis (p <0.05). APUD
cells had different shapes, mostly irregular, were identified to
produce serotonin.
Conclusions: We have revealed the reliable increase of APUD cells in
ovarium endometriosis as in locus of endometriosis, so and in endo-
metrium of this patients compared to normal endometrium of
patients with adenomyosis.
Outlook and Expert recommendations: Neuroendocrine, APUD cells
signaling and serotonin are important and not sufficiently studied
mechanisms for number of pathologies of different localization, and
link amongst series of pathological processes including obesity, CVD,
cancer, etc. Serotonin is a primal signaling molecule that is impli-
cated in the control of energy balance.
There should be a sufficient evidence study to determine relation-
ships among APUD cells signaling and serotonin with endometrial
receptor system, genetics, microbiome, immune pathways, apop-
tosis and vascular patterns to complement the diagnostic algorithm
that will allow the development of novel treatments and model-
guided approach.
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Introduction: Endometrium hyperplasia (EH) is of huge importance in
gynaecological morbidity. The debatable nature of aetiology pathogen-
ous moments, insufficient classifications, the risk of changes leading to
cancer and cancer of endometrium determine the topicality of this
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problem for women, those of the pre-menopause age in particular
[1-3].
The aim was to update the EH treatment effectiveness via predictive
diagnosis and personalized pathogenesis-based treatment algorithm
in pre-menopause age patients.
Materials and Methods: We included to the study 161 women with
the EH (age from 45 to 56, the average age 49.3 ± 2.3 tears), the
patients of clinical hospital “Pheophania” and Kyiv Maternity Hospital
N3.
Patients underwent clinical examination, the diagnostic hysteroscopy
with the obligatory cervical channel and uterus cavity scraping off,
and following histological diagnosis verification and the endomet-
rium receptors phenotype identification.
Endometrium hysteroscopic ablation was performed using
«KarlStorz» hysteroresectoscope (Germany). The transvaginal ultra-
sound was performed twice, after 1, 3 and 6 months after surgical
intervention.
In order to define the differentiated tactics for the patients’ treat-
ment, the age, EH form and the presence of the collateral somatic
and genital pathology were taken to consideration.
Results: The investigation of reproductive system’s organs of women
with EH in pre-menopause defined the following frequency of the
gynecological pathology: fibroid tumor - 54 (33.5 %) patients, adeno-
myosis - 32 (19 %) patients, breast - 28 (17.3 %) women. The analysis
of the extra genital pathology structure of women with EH stated the
following frequency of the cardiovascular system disorders 62
(38.3 %), hepatic biliary system diseases - 39 (24.2 %) and neuro neu-
roendocrine disorders - 56 (34.7 %) patients.
While developing the differentiated treatment program, we consid-
ered the age of a woman, endometrial histological peculiarities
(including the receptor phenotype, presence of the accompanying
somatic and genital pathology); it provides one with the possibility
to single out the patients who have the contra-indication to hormo-
nal therapy and whom the surgical intervention is likely to be
recommended.
EH is accompanied by the receptors quantitative and qualitative
features which are worth taking into account while developing the
personalized tactics of treatment, if ER/PR ≤ 1.0, the progesterone
drugs therapy is preferable. In case the ER/PR correlation is over 1.0
and in case of receptors to progesterone decrease, GTRG are to
be used for menolipsis and physiological correlations of receptors
systems renovation.
All this data allowed to distinguish group of patients with contra-
indication to progestin hormone therapy, the group of patients who
were prescribed aGTRG antagonists or surgical teatment (interven-
tion). In case of contra-indications to hormonal therapy and EH
relapse’s development without atypical features, women of pre-
menopause age should undergo the endometrium hysterescopic
ablation which is the alternative to both continuous hormonal and
radical surgical intervention.
Conclusions: Appropriate assessment in pre-menopause women with
endometrial hyperplasia the broad panel of diagnostic and pre-
dictive markers, including analysis of receptor phenotype, somatic
and genital pathology, planning surgery allows suggesting effect-
ive algorithm of personalized treatment.
Outlook and Expert recommendations: An international women's
health project including the study of integrative diagnosis ovaries,
endometrial pathology, cervix, breast a in regards to health aging
for stratification patients for personalized therapies; organize edu-
cational programs should be created. There should be a sufficient
evidence study to determine relationships in endometrial receptor
system, genetics, microbiome, immune pathways to complement
the diagnostic algorithm that will allow the development of novel
treatments and model-guided approach.
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Now the set of certificates on interrelation of inflammatory diseases
of parodont (IDP) and various internal diseases are saved up. Univer-
sal molecular and cellular deviations, violations of energetic meta-
bolism, pathological activation of apoptosis, immuno-pathological
reactions, disbalance of presence of the major macro - and microele-
ments in various biological environments, supplementing each other
in the form of self-sustaining system, promote development and pro-
gressing of many somatic diseases and IDP associated with them.
The interconnected pathogenetic links of the polimorbid diseases
can be united in a polimorbid continuum. Results of our research
works at the polimorbid patients showed increased activity of free
radical oxidation of lipids and tiols, high level of markers of an early
stage of pathological apoptosis of cellular receptors of CD 95+ (р<
0.01), reduction of activity of macrophages, high level of the circulat-
ing immune complexes in blood (р< 0.01) and disbalance of macro -
and microelements- magnesium, calcium, copper, zinc, iron in the
bioenvironments of an organism.
Multi-purpose monotherapy of the polimorbid patients is a kind of
perspective treatment by the usage of one medicine for simultaneous
correction of the broken functions of several systems. The special at-
tention is paid to the metabolic drugs with the universal complex of
mechanisms, and possessing metabolic, antioxidant and antiapoptotic ac-
tion. Such effects were established using a сerebrolysin, cytoflavin, mexi-
dol, mildronate, cycloferon. The choice of a medicine must be motivated
by the account of the prevailing pathology in a polimorbid complex and
indications to application of the chosen mean of multimodal therapy.
Such tactics provide a personified approach to the appointed treatment.
Conclusions
1. Polimorbid patients with IDP need the complex inspection includ-
ing an assessment of an oxidizing stress, immunological shifts and
balance of macro - and microelements.
2. The polimorbid patients with the combined IDP treatment must in-
clude the means of multi-purpose pathogenetic monotherapy.
3. Interdisciplinary aspects of pathogenesis of IDP demand cooper-
ation of dentists and internist for the joint maintaining of the poli-
morbid patients.
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Introduction: The era of local wars greatly increased incidence of
mine-explosive wounds (MEW): they accounted for 13 % up to 76 %
in war history. While ensuring antiterrorist operation (ATO) we
observe the growing number of wounded servicemen with mine-
explosive wounds, affecting many areas of the body and develops
post-contusion-commotion syndrome, leg injuries. Use of kevlar
helmets, body armor, in many cases saving the head, chest, so the
fore limb damage. Injuries of limbs in the structure of surgical
sanitary losses prevail over the other injuries, many of the wounded
are amputees and suffer from severe infections, including
gangrene.
The aim was to analyze the structure of radiology / ultrasound diag-
nosis at tertiary level military clinic during the anti-terrorist operation
(ATO) in the East of Ukraine.
Materials: We analyzed clinical records of wounded patients, who
underwent examination in Ultrasound department of Ukrainian
Military Clinical Hospital working in enhanced mode during the
Ukrainian Revolution of Dignity and ATO (January 2014 to January
2015).
Ultrasound was conducted in 2789 patients, among them 1305 (48 %)
patients with mine-explosive wounds, with different nature of injuries.
The average age of injured males surveyed amounted 37.9 ± 13.6 years.
When screening via ultrasound survey patients were divided into two
groups: surgical patients in 1345 individuals (48 %), affected therapeutic
profile in 1444 patients (52 %). According to localization in anatomical
and topographical sections lesions wounded were divided into 5 groups:
head and neck (group 1; 22 %), chest and upper limbs (group 2; 13 %),
abdomen (group 3; 31 %), bowel and the lower extremities (group 4;
34 %).
X-ray, CT, MRI were used for diagnosis cranial, orbital pathology, to
identify anatomical and topographical location of foreign bodies
(shrapnel, bullets, drainage, tampons, various fragments of shells).
The initial stage of diagnosis algorithm of wounds was ultrasound.
Results and Discussion: According to our records 58 % of injuries
were combine damages of liver, spleen, kidneys, retroperitoneal, sub-
capsular organic and extraorganic hematomas, hemotorax, hemoper-
itoneum, hemoscrotum, hemophthalmia that in general was
gunshots wounds prevailed in the structure of all damages and is
69 %. Organs contusion induced splanchnomegalia and enhanced
vascularization.
57 % of surveyed patients of therapeutic profiles had acute reactive
states, neurological, angio-neurological, neurosurgical conditions. In
53 cases with blunt head trauma (closed head injury, concussion,
acute acoustic trauma, wounds coal face, scalp, concussion) we regis-
tered reduction of blood flow in the vertebral arteries.
The injuries of extremities ranged over 65 %. Deep veins thrombosis
(DVT) of the lower extremities was found in 45 (32 %) patients with
mine-explosive wounds, asymptomatic DVT was diagnosed using
Doppler ultrasound. We successfully used share wave sonoelastogra-
phy (SEG) to study the elasticity of thrombus. Thus, the average
values of the clot elasticity "fresh" blood clots, blood clots with high
risk for embolization was 1.39 ± 1,14 kPa; for blood clots boundary
degree of risk of embolization – 2.89 ± 0.50 kPa; for "consolidated"
blood clots – 7.82 ± 0.39 kPa. In 29 (40 %) of cases we detected
changes in soft tissies on SEG that were not detected in the gray
scale mode, as an intermediate type mapping (yellow-red staining,
Young modulus was 98.8 ± 45.1 kPa), indicating that intramuscular
hematoma with areas of fibrosis, scars to replace the tissue gaps.
Conclusions: Analyzing the large clinical data we observed the prevail-
ing of gunshots, shrapnel wounds, mines and explosive damage of any
affected multiple parts of the body. When using personal protective
equipment limb injuries are dominant. Ultrasound is the primary method
algorithm for screening and diagnosis of traumatic injuries. The use of
Doppler and sonoelastography of extremities allows to diagnose asymp-
tomatic thrombotic complications in peripheral vessels at different times
after injury.
Outlook and Expert recommendations: Antiterrorist operation (ATO)
provided large clinical data with systemic medical records collection
for analysis and research to predict and prevent injuries in the future.
Early measures (innovative first aid and wound care) to prevent am-
putations and complication are needed to be implemented. Develop-
ments of rehabilitation centers network, and further socialization
using broad volunteer activity is an urgent need. Delivery of person-
alized prosthesis and replacement technologies via multidisciplinary
smart solutions is strongly needed (e.g., using 3D modeling, 3D print-
ing, etc.) for improvement of quality of life of patients.
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Purpose: In recent years, multiplex microbead technology has been
increasingly used to identify novel biomarkers of ocular surface disease
via tear fluids. These studies, however, have also highlighted differ-
ences in tear fluid sampling across laboratories. We have performed a
standard operating procedure (SOP) to optimise tear fluid retrieval and
storage methods, versus cytokine expression, using magnetic multiplex
bead arrays.
Methods: Pooled tear fluid samples underwent microarray bead ana-
lysis for 7 cytokines (IL1-β, IL-2, IL-6, IL-8, IL-17A, IFN-γ and TNF-α)
using various tear sampling and storage techniques. A standard
method of using 1ul tears in a 50x dilution was used throughout the
study, except when looking at the effect of different tear volumes on
cytokine detection.
Conditions Tested
Lo-Bind eppendorfs versus standard microfuge tubes
Multiple freeze/thaw cycles
Retrieval: Schirmer strip versus microcapillaries versus minisponges
Different tear volumes (1μl, 3μl, 5μl)
Sample storage (-20 °C versus -80 °C)
Results: Multiple freeze/thaw cycles showed significantly reduced
levels of IL1-β and -2 and showed a trend for a reduction in the
other 5 cytokines. Levels of IL1-β and TNF-α were significantly dimin-
ished for tears stored in standard eppendorf tubes, versus Lo-Bind
eppendorfs. Moreover, IL-2, -6, and -17 were significantly reduced in
tears collected with a Schirmer strip versus a microcapillary. There
were significant reductions in IL-8 and IFN-γ in tears retrieved using
a minisponge versus microcapillaires. No significant difference was
observed for tears stored at -20 °C versus -80 °C. A general trend for
reduced cytokine levels was observed as tear sample volumes in-
creased (1 μl versus 3 μl and 5 μl). This reduction was found to be
significant when comparing 1 and 5 μl volumes for IL1-β and 17A.
Conclusions: Differences in tear fluid recovery and sample storage may
affect cytokine detection by multiplex arrays. This may be due to sam-
ple dilution and inherent matrix effects, varying degrees of protein
binding affinities of lab plastics used for storage, and sample sublim-
ation. A standardised operating procedure for tear fluid retrieval and
storage would benefit future studies of cytokine expression in dry eye
disease. It is anticipated that the preliminary data generated here will
serve to inform a more standardised protocol across laboratories.
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Aim: Some women experience inflamed and bleeding gingival prob-
lems and aphteous stomatitis due to hormonal imbalance during
menstrual cycle. The sex hormones such as estrogene and proges-
trone affect angiogenesis which eventually increases vascularization
of gingival tissues. Since not all women have these problems, some
cofactors should be investigated as etiologic factors. Therefore, the
aim of this study was to analyze the effects of dietary habits on gin-
gival changes during menstruation.
Material and Methods: 30 women aged between 18 and 25 on the
1st and 3rd day of menstruation were included in this study. The
plaque index and gingival index scores were recorded. The women
also filled the questionarre of ‘Healthy Eating Index” forms and pos-
sible correlations were statistically analyzed.
Results: Overall scores of ‘HEIndex and gingival inflammation were
not correlated. However, the analysis of each food sub-group showed
that fruit consumption was negatively correlated with plaque and
gingival index, while ‘empty calorie consumption’ was positively cor-
related with gingival inflammation(p < 0.05).
Conclusion: Dietary consultations can be added to routine periodon-
tal treatment for better therapy outcomes.
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Background/Objective: Prostate cancer (PCa) is a major health
problem worldwide due to its prevalence, morbidity and resource
management associated. The applicability of personalized medicine
will improve the patient and socio-economic management of this
disease.
Prolaris is a novel biomarker for PCa used as an oncogenomic test,
which has been validated retrospectively in over 8000 patients as
prognostic and predictor factor for cancer-specific mortality and
metastatic disease [1, 2].
Objective: To assess the usefulness of Prolaris to enhance the hetero-
geneity of the current risk groups and the impact on the personal-
ized management of localized prostate cancer (LPCa).
Methods: A Spanish cohort of 284 LPCa patients (2013-2014) were
analyzed and Prolaris was applied. Sections (2-4 mm) of tumor tissue
samples embedded in paraffin were obtained from biopsies and sent
to Myriad Genetics to apply the Prolaris test. Age, PSA, Gleason,
number of biopsy cylinders, percentage of tumor affected and
clinical state (cT) from patients were recorded. Bio-bank and local
ethic committee approved informed consent were signed by all
patients.
AUA tumor risk (PSA, Gleason and cT) was estimated by comparing it
with the risk provided by the expression analysis (Prolaris-CCP score).
Inferential analyzes were performed using Chi-square.
Results: The comparative analysis between AUA risk and Prolaris risk
showed only a concordance of 40.5 % in the overall series, 41.3 %
for low-risk tumors, 46.9 % for intermediate risk tumors and 34.7 %
for high-risk tumors (Fig. 1, p <0.05). According to these results, the
application of the parameters used in routine clinical practice would
incur in an underestimation of the risk of 39 % and an overesti-
mation of 20.1 %.
Conclusions/Recommendations: Individualized risk assessment of
LPCa by Prolaris test allows better accuracy discrimination of tumor
heterogeneity of the different actual risk groups. The clinical
applicability of omics tools could improve our strategies in the
selection of patients for different therapeutic modalities.
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Background: Our unit consists of three centers attending a health
area of over 1 million people; therefore our ability to recruit and
include patients in projects is very high.
The unit has previous experience in the development of studies
related to molecular oncology, new biomarkers and personalized
medicine. Our unit is included within the Biomedical Research Insti-
tute of Malaga, and has a laboratory of oncology and molecular im-
aging (NGS, Ncounter, PCRreal-time, isoflux-CTCs, cDNA, PET-MRI3T
Fusion).
Objectives: Prostate cancer (PCa) is a major health problem world-
wide due to its prevalence, morbidity and resource management
associated. Bladder cancer (BC) is the most expensive oncological
disease due to the chronicity of non-muscle-invasive tumors, the
radical treatments and the systemic therapies for infiltrative
disease.
Our main activities in the uro-oncology are focus on:
i) PCa: The overall aim is to develop and assess a personalized medi-
cine program on localized PCa intended for the detention of clinical
significant and non-significant tumors as well as to establish at-risk-
population profiles based on the combination of omic tools, genetic,
epigenetic, preventive, risk factors and lifestyles, as compared with
the parameters of conventional clinical practice.
The results will enable to adopt novel preventive and therapeutic rec-
ommendations within the health system with the aim of decreasing
over diagnosis and overtreatment on non-significant PCa; selecting
suitable candidates for initial curative-intended treatments; decreasing
morbimortality in additional procedures; improving the quality of life
Fig. 1 (abstract A33). Tumor aggressiveness by AUA and
Prolaris risk.
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and psychosocial effects derived from unnecessary treatments; and
readdressing policies leading to an improvement in health as well as to
the optimization of social, health and economic resources.
ii) BC: There are several patients susceptible to high cancer-specific
mortality, in which it is crucial to incorporate new predictive and prog-
nostic diagnostic tools and to identify new targets that establish new
treatments or optimize the current one, in order to improve survival.
The overall aim of our research is to establish a new taxonomy in
bladder cancer by comprehensive analytical strategy of various mo-
lecular pathways in order to identify candidates for new-targeted
therapies and implementing them in clinical practice.
Conclusions:
PCa and BC are two oncological diseases that may benefit of novel
therapeutic strategies; many of them will derive from the applicabil-
ity of the omics sciences and personalized medicine. Therefore, it is
important to incorporate new models of health-care based on indi-
vidualized risk profiles and to establish indicators and evidence of
the suitability of these models of personalized medicine to be incor-
porated into health policies.
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Redox and pH reactions involve electron and proton transfers in
chemical and biological systems, whereby deviations from normal
values are defined as oxidosis/redosis and acidosis/alkalosis, res-
pectively. Cancer cells are depicting a constant redosis state with an
increased accumulation of reduced glutathione, NADH, NADPH, cyst-
eine, glucose and transitional metals, respectively. Consistent with
their redosis state, proliferating cancer cells show a permanent intra-
cellular alkalinization (pHi 7.12-7.65) when compared to normal cells
(pHi 6.99-7.20) related to an obvious HIF1 and aerobic glycolysis acti-
vation, known since 1930 as “Warburg effect”.
The constant intracellular alkalinization of proliferating cancer cells is
closely related to a highly increased activity of the Na+/H+ Antiporter
system, of the V-ATP-ase proton pumps and of the MCT lactate trans-
porters, all of them leading to a continuous excretion of protons (H+)
and lactate in the extracellular milieu. Zn-dependent carbonic anhy-
drases (CA2, CA9, CA12) are also contributing to the acidification of
the extracellular tumor environment (pHe 6.2-6.9) when compared to
normal tissue (pHe 7.3-7.4). This acidic milieu is promoting both the
tumor growth with metastatic spreading and the inhibition of im-
mune competent cells.
The above-mentioned molecular-biological hallmarks gain an import-
ant role in the diagnosis and treatment of therapy-resistant neoplas-
tic disorders. New integrative therapy approaches with significant
antiproliferative and pro-apoptotic effects may include:
(1) The elimination of the intracellular redosis state by means of pro-
oxidative approaches,
(2) The use of i.v. basic solutions for buffering the extracellular acidic
state,
(3) The usage of high-dose Vitamin C and polyphenolic compounds
leading to in situ high ROS generation in the presence of metal-rich
tumor cells,
(4) Pharmacologic inhibition of proton pumps, Na+/H+ antiporter sys-
tems and carbonic anhydrases,
(5) The choice of appropriate diet forms with low glycemic index and
high ketogenic and pro-oxidative properties and
(6) The inhibition of key enzymes of aerobic glycolysis.
These therapeutic interventions alone, or in combination with clas-
sic oncology treatments can significantly increase the lifespan and
life quality.
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The study of the genetic basis of periodontal lesions on the back-
ground of peptic ulcer is an urgent task. Identification of genetic
systems, their pleiotropic effects will clarify the genetic basis of peri-
odontal disease and closer to the mechanisms of interaction of poly-
genic systems implementation of genetic information at the level of
the whole organism [1-3].
The objective was to analyze the association of clinical manifesta-
tions with polymorphic variants of genes IL-1β and IL-1RN on the
course of periodontal disease.
We examined 100 patients with periodontal disease, comorbidity
of the gastrointestinal tract and 117 healthy blood donors. Using
molecular genetic methods based on DNA extraction, polymerase
chain reaction, restriction analysis, the method of polyacrylamide
gel electrophoresis were identified polymorphisms T511C (+3953)
A1/A2 in the gene IL-1β and VNTR polymorphism in the gene an-
tagonist of IL-1.
Patients revealed the association 3953 polymorphism A1/A2 gene IL-
1b, what proved the influence of genotype A1/A2(tt) and A2/A2(tt)
on the severity of periodontitis. Patients with different genotypes for
the polymorphism 511(C/T) gene IL-1b did not differ in frequency of
inheritance of gastric ulcer and 12 duodenal ulcer (χ2 = 0.065; df = 2;
p = 0.45). A similar trend was observed when comparing the allele
(χ2 = 0.052; df = 1; p = 0.77). In patients with different genotypes and
alleles in VNTR polymorphism of the gene IL-1Ra also did not differ
in the frequency of occurrence compromised hereditary history for
the development of somatic pathology by comparing allele (χ2 =
0.329 and χ2 = 0.028, p > 0.05, respectively).
The study to the association of the VNTR polymorphism of the gene
IL-1Ra with the development of the disease, proved the influence of
A1/A2, A2/A2 on the severity of inflammatory and destructive pro-
cesses in the periodontium.
This polymorphism as a predictor of the development of severity,
predict the dynamics of periodontal disease, contributing to the justi-
fication of a predictive, preventive and personalized medicine [4, 5].
The use of targeted immune will lead to a pathogenetic approach in
the treatment of periodontal lesions.
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Diabetic macular edema (DME) is one of the most common DR compli-
cations. The incidence of DME is in approximately 50 % of the diabetic
subjects. In mild form of diabetes, it is present in 3 %, while in moder-
ate NPDR rises to 38 %. In eyes with PDR the incidence of DME reaches
71 % [1].The mechanism of action is in direct connection with chronic
retinal microvascular damage. This causes an elevation of intraocular
levels of vascular endothelial growth factor A (VEGF), a potent,
endothelial-specific mitogen. The production of VEGF A leads to in-
creased permeability of the vasculature and developing of edema [2].
Through history, the standard of care for DME has been laser photo-
coagulation, which has shown to be effective in stabilizing of vision
and reducing the rate of further vision loss by 50 %. Macular laser leads
to vision recovery in only 15 % of treated patients [3]. Ocular pharma-
cotherapy includes the intravitreal drug applications, such as corticoste-
roids and Anti-VEGF drugs. Among different side effects, one of the
greatest problems is the repeated application of the drugs [4].
Medical care plays a crucial role in the prevention of diabetic eye
complications. Lower levels of glycosylated hemoglobin (HbA1C) are
associated with lower incidence of DME. Study results: An increase of
1 % of HbA1C was associated with a 22 % increase in the 21-year
cumulative incidence of DME [1]. Severe hypoglycemic episodes lead
to development of DME. A speeded up improvement of the glycemic
control lead to rapid worsening of the DME. Patients with DR and
DME have significant increase of retinal vein pressure compared to
normal subjects [5].
Despite continued improvement in the diagnostic techniques, DR re-
mains the leading cause of blindness in working-age populations. Ac-
cording to the life style and the life expectance, we have to change the
old screening or treatment diabetic programs. Genetic investigations
should be the first level of the screening goal. Among the risk popula-
tion, an interdisciplinary approach should have a mandatory role in pre-
vention of diabetic eye complications. Visual test self-control and
distribution to an eye-reading center should be an important part in
detection of the early eye changes in diabetic patients.
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Among the cornerstones of PPPM there is laboratory medicine (LM).
EPMA finds it essential that all relevant expert organizations contribute
with their expertise and their complementary visions and ideas to PPPM
and help to change the paradigm from the current reactive medicine to
the active PPPM with predictive diagnostics, targeted prevention, person-
alized treatment and consequently create new, perspective and desired
healthcare system which would be the long-term alternative and comple-
ment to the current system of disease-oriented “disease care”.
The following actions will be taken into consideration for further co-
operation and development of EPMA strategies in LM, relevant for
PPPM and advancing healthcare:
1. Systematic classification of all types of predictive markers
2. Establishing new requirements for data and knowledge
processing in clinical laboratory information systems from the
PPPM perspective
3. Further extension of LM which should include analyses of the
external-factor-based materials influencing health
4. Cooperation on the EPMA envisioned PPPM center
5. Supporting necessary cooperation between PPPM, biobanking,
bioinformatics and LM
6. Common education of experts in PPPM and LM
7. Cooperation in grant schemes in order to acquire financial
resources for further development of technologies and
interdisciplinary research in PPPM and LM
8. Publication activities promoting PPPM and LM
9. Common meetings and roundtable discussions dedicated to
complex interdisciplinary cooperation and application of the
achievements into practical procedures in medicine and healthcare
10.Cooperation in fund raising and promotion of both PPPM and LM
11.Research cooperation in PPPM and LM
12.Political activities related to the role of PPPM and LM in
advancing healthcare
The overall cooperation between all professional medical organizations
and fields is not only mutually beneficial but also essential. EPMA
considers it to be the duty of all medical experts and scientists to use
available expertise and knowledge to create vital conditions for an
inevitable change in the way people care about their own health.
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Medical travel (MT) is defined as a package of services provided to
the person (healthy or diseased one) that is health/life important,
however, not available near his/her home. EPMA considers PPPM
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concepts as being the most optimal in effective organisation of MT,
namely individualised deep diagnostics, targeted preventive mea-
sures and treatments tailored to the person. Service packages of ad-
vanced MT are distinguishable in five categories:
1. Primary MT: specialised medical resources and treatments (e.g.
highly specialised transplants)
2. Revalidation (e.g. neurological revalidation after an accident)
3. Wellness (integrated medical servicers, health supporting care, predic-
tion, prevention and treatment of individual predisposition to pathologies)
4. Spa (specialisation in certain diseases/predispositions, such as arth-
ritic or liver diseases)
5. Home care for older people (possibility of trans-mobility within
and outside the Europe).
European concepts for effectively organised MT foresee strong pro-
fessional networking and clustering of specialised medical centres
which fulfil the strict criteria of excellence that are conform to the
PPPM concepts and principles presented in the EPMA White Paper
created by the leading specialists from over 40 countries [1].
As reported earlier EPMA has nominated a working group which
elaborates the criteria for centres of excellence in PPPM [2].
Criteria to be considered in individual countries for participation in
the EPMA-MT network are political stability, strong scientific contri-
bution to PPPM concepts and implementation, unique medical ex-
pertise contributing to the above pointed categories 1-5, developed
infrastructure, good accessibility via means of transportation, well
established network of medical facilities offering high quality of medical
services to reasonable costs, high standard hotels, favourable ecological
situation (preserved nature with tourist paths in the area, fresh water
resources, food quality control, etc.), opportunities for a wide range of
sports and cultural activities, customer friendly attitude to visitors, and
opportunities for investments in this type of medical services.
European countries and international organisations are invited to fol-
low the EPMA initiative for an optimal organisation of MT within and
outside the Europe. A series of meetings dedicated to the European
concepts and professional networking in MT is organised by the
EPMA such as the specialised workshop on MT, “EPMA World Con-
gress 2015”, Bonn, Germany; “European MT”, specialised workshop at
the European Parliament, Brussels, Belgium, March 2016, etc.
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The aim of this contribution is to summarise an interdisciplinary ap-
proach to explain personalisation through design. It examines the
design processes in the innovation of e-textiles and subsequently
proposes a framework, which exposes the relationships between the
actors in innovation, the design process and ‘design thinking’ and
their application to personalised medicine. It focuses on a significant
and complex new area of e-textiles that ‘host’ ICT by integrating elec-
tronic components. It evaluates the recent history of innovation in e-
textile technology in the contexts of design practice as an innovation
ecosystem. When focused on e-textiles, an interdisciplinary approach
offers insights that can both delineate design’s role in innovation,
and point towards specific innovations. Efforts to define the relation-
ships between design and other actors in the ‘ecological’ networks
that bring about innovation are likely to increase understanding of
both the potential of design, and productive ways to encourage such
networks. As this research originates in both design practice and aca-
demic design research it is well placed to demonstrate the rela-
tionships that make up such networks. The review concludes that
e-textiles can make a valuable contribution to PPPM by mediat-
ing information through smart clothing and accessories. Both the
design of e-textile objects and design of their place in the PPPM
ecosystem will contribute to more effective personalised medicine.
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Biobanks and Biomolecular Resources Research Infrastructure - European
Research Infrastructure Consortium (BBMRI-ERIC) is one of the largest
European infrastructures, consortium consisting of 54 members with
more than 225 associated organizations, mostly biobanks from over 30
countries in Europe. BBMRI-CZ was established under the governance
of the Ministry of Education and became a founding member of the
European biobanking infrastructure BBMRI-ERIC. The Czech consortium
is coordinated by Masaryk Memorial Cancer Institute in Brno and
the following members are: Charles University (1st Medical Faculty
in Prague, Medical Faculty in Hradec Králové, and Medical Faculty in
Pilsen), Palacky Universtity Olomouc (Medical Faculty).
The main purpose of biobank in Pilsen is to establish a platform for
the research and for national and international cooperation. Main
topics for research at the Faculty Hospital in Pilsen and at the Medical
Faculty – Charles University in Pilsen are related to the use of bio-
markers in oncology, particularly for: prevention – active search for risk
factors, early diagnostics, therapy effect monitoring, prognosis estima-
tion, and recurrence disease and disease progression diagnostics.
Main problems to be solved now are: definition of the character and
purpose of the biobank, choice of individuals and frequency of the
monitoring, pre-analytic problems (solved), data quantity and quality,
unified system of the storage, ethical issues solution on the national
level that has been currently missing.
We assume that multidisciplinary team of specialists, functioning in-
frastructure and harmonizing all necessary processes enable that the
biobank will not serve only for the local hospital purpose, but it will
play an important role for the national and international cooperation.
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Today huge amounts of data are generated by the omics disciplines
and clinical data are collected in patient data management systems
for more than 20 years now. There is the hope that big data will lead
to a more effective and more personalized medicine. But how and
how quickly will big data transform healthcare?
I will elaborate on the following key challenges of big data: stan-
dards, integration, and statistical analysis where I will focus on bio-
medical data. Many groups of scientists have been working on
establishing the relevant data standards for omics data. They in-
clude standards for experiment description, data exchange, termin-
ology, and experiment execution. I will introduce MIAME (Minimum
The EPMA Journal 2016, Volume 7 Suppl 1 Page 20 of 42
Information About a Microarray Experiment) [1] and some analogs
for other omics data.
An important goal of data standardization is the simplification of the
subsequent data integration [2], i.e., the combination of data of dif-
ferent sources to provide a unified view on these data. I will briefly
summarize some current approaches in personalized medicine such
as The Cancer Genome Atlas Project (TGCA) [3]. In the last part, I will
talk about the statistical analysis of big data [4]. Here I will sketch the
workflow of building predictive models by applying modern statistical
machine learning methods. In particular, I will present PATIENTS one of
my projects that aims at the development of patient-specific learning
methods [5].
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Many strategic and tactical issues are to be resolved for implementa-
tion of predictive and preventive measures for various dental dis-
eases. On September 13-15, 2011, in Bonn, Germany, the Board of
the European Association for Predictive, Preventive and Personalised
Medicine (EPMA, Brussels, Belgium) made a decision to establish the
European Department of Dentistry (DPPPD). The task was assigned
to the Head of the Therapeutic Dentistry Department of Voronezh
State Medical University, the Director of the Dental Institute, Dr. Med.
Sc., Prof. Anatoly A. Kunin. The Department was officially opened at
the International Dental Congress held on February 24, 2012, in Vor-
onezh, Russia, in the presence of the EPMA Secretary-General Prof.
Olga Golubnitschaja and 32 professors from 8 countries participating
in the roundtable discussions. Over the three-year period of its exist-
ence, the EPMA European Department of Dentistry has carried out
certain works on promoting prediction and prevention of dental dis-
eases in the DPPPD member countries. Italy, The United States,
Estonia and Russia have taken the most active part in this direction.
The work resulted in organization and coordination of the Dental
Section at the EPMA World Congress held on September 19-21, 2013,
in Brussels, Belgium. Scientific reports and their discussion under the
program made a certain contribution to the development of diagnostic
predictive and preventive techniques in dentistry. Some of them should
be distinguished: preclinical diagnostics of dental caries (light-induced
fluorescence and electrical conductivity of dental hard tissues; cyto-
logical and bacterioscopical indicators of initial oral manifestations; nor-
mal and pathological values; different options of dental hard tissues
micro-damage in dental caries treatment; high-tech methods for caries
and periodontal diseases prevention; numerous studies of consumable
items for dental caries prevention, and many other things.
Special emphasis should be placed on the strategically important EPMA
activities based on the consolidation of 45 participating countries and
their vigorous interdisciplinary activity focused on Future Medicine
where the 3P (predictive, preventive and personalized) approach based
on up-dated biomedical techniques and developments is a priority.
That is the reason why the Innovative Centers established on the
basis of the European Department of Dentistry provide high-tech
medical services with due consideration of a personalized approach
for patients.
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Introduction: Endometrial hyperplasia (EH) holds leading position
in the structure of gynecological pathology, evoked by changing
women lifestyles, widespread abortion, collateral diseases and limita-
tions of conservative treatment due to the contraindications to hor-
mone therapy. Endocrine factor is crucial [1-3], however not the only
a part of EH pathogenesis, hormonal reception disorders, are related
to immune responses and apoptosis, etc. Therefore, identification of
new pathogenic mechanisms of EH, including immunological, develop-
ment on results of these studies of new therapeutic and diagnostic
approaches will improve outcome and timing of treatment, quality of
women life.
The aim was to study the levels of cytokines in flushing from the
uterus in women with endometrial pathology.
Materials and Methods: We included to the study 192 women who
passed the survey and were treated at the General Gynecology
Center of Clinical Hospital “Pheophania”. Age of women ranged from
22 to 83 years and averaged 46,0 ± 8,3 years; in reproductive period
there were 54 (34.6 %) patients, 49 in premenopausal (31.4 %) and
53 in postmenopausal (34.0 %) cases. The control group (n = 36), was
formed by three sub-groups, which included 12 (33.3 %) women of
each age period. Patients were divided into 7 groups: the first group -
patients with simple EH (n = 28 (17.9 %), the second group consisted of
patients with simple EH with atypia (n = 24 (15.4 %), the third group
represented by patients with complex EH without atypia (n = 24
(15.4 %),25 (16.0 %) women with complex (adenomatous) endometrial
hyperplasia with atypia made up the fourth group, the fifth group - 31
(19.9 %) observations - women with endometrial polyposis (EP) and
sixth group - 24 (15.4 %) women with endometrial cancer (adenocarcin-
oma). The sixth group included patients with first stage of endometrial
cancer. The seventh control group consisted of 36 healthy examined
women.
All the patients underwent general clinical examination, indications
for hospitalization were the results of transvaginal ultrasonography
(ultrasound signs of EH). All patients underwent hysteroscopy with
further diagnostic scraping the walls of the uterus and cervical canal.
Determination of the concentrations of cytokines IL-1, IL-2, IL-6 and
TNF performed solid enzyme-linked immunosorbent assay by means
of commercial reagent kits produced by LTD "Cytokines" (St. Petersburg,
Russia).
Results: Simple non-atypical endometrial hyperplasia accompanied
by an increase in flushing from the uterus of TNF level, IL-1 β level,
IL-6 and IL-2 by 2 times.
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The presence of complex non-atypical endometrial hyperplasia ac-
companied by an increase in flushing from the uterus of TNF levels
by 1.5 times, increase levels of IL-1β in 3-4 times, higher levels of IL-6
by 2 times and IL-2 by 1.5 times.
Pro-inflammatory cytokines level in flushing from the uterus in
women with atypical forms were sharply increased. Thus, the level of
TNF exceeded the reference values by 5-6 times the level of IL-1β in
a simple EH with atypia – by 5 times, with complex EH with atypia -
10-11 times. The content of IL-6 in flushing from the uterus in pa-
tients with simple EH with atypia was increased by 6 times, with
complex EH with atypia – by 10 times. The level of IL-2 increased in
these groups by 2.5 times.
Endometrial polyposis accompanied by increased pro-inflammatory
cytokines (from 2 to 6 times), but is characterized by wide fluctua-
tions in values, in our opinion, due to the presence of combined
chronic process in the uterus.
In malignant transformation of the endometrium there is a significant
increase in local inflammatory cytokines in the uterus, which charac-
terizes the maximum activation of immune defense mechanisms,
and appears increasing of TNF and IL-6 in 11-12 times, IL-1β in 25
times and IL-2 in 2.5 times.
Conclusion: The development of endometrial proliferative processes
is accompanied by a local increase in the levels of pro-inflammatory
cytokines, correlating with degree of pathological transformation of
the endometrium.
Outlook and Expert recommendations: Defining the level of pro-
inflammatory cytokines in the uterus may be used as diagnostic deter-
minants in defining the nature of intrauterine pathology and criterion
of efficiency of conservative therapy phase.
There should be a sufficient evidence study to determine relation-
ships in endometrial receptor system, genetics, immune pathways
and vascular patterns to complement the diagnostic algorithm that
will allow the development of novel treatments and model-guided
approach.
Vaginal / uterus microbiome studies are necessary in the various
stages of disease and in different at-risk populations, in regards to
the role of host genotype, involvement hormonal receptors might
suggest promising approach for understanding pathogenesis of
chronic gender-related inflammatory diseases, development person-
alized treatments, diet and lifestyle corrections [4].
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Macrophages are the cells responsible for the initiation of the for-
eign body response and therefore regulate the immune reaction to
implant materials. Adverse reactions of macrophages result in the
individual profile of inflammatory complications caused by titanium
implants, therefore innovative coating materials are under develop-
ment in the leading laboratories in the world. A promising biomate-
rial is Polylactic acid (PLA) which provides high biocompatibility,
processability and good mechanical properties. PLA is a synthetic
biodegradable polymer used in manufacturing of implants and coat-
ings such as resorbable sutures, clips, plates and screws and in drug
delivery devices. However, degradation of PLA in the body into lac-
tic acid can cause chronic inflammation and implant intolerance. To
address this issue, surface modifications of PLA-based biomaterials
may be used. Macrophages regulate the inflammatory reaction to im-
plants, therefore their response to unmodified and modified PLA-based
materials was analyzed. We found that human primary monocyte-
derived macrophages react in a donor-specific way to PLA samples
modified with Brilliant Green dye (BG1, BG2, BG3) and that these modi-
fications had a stimulatory effect on the production of TNFα and CCL18
released by both M1 and M2. Additionally we studied the expression of
macrophage mannose receptor CD206 and stabilin-1 to analyze whe-
ther modified or unmodified PLA samples can induce an M2 tole-
rogenic phenotype in monocytes. We found that unmodified PLA
samples increase the expression of both markers, while the modified
PLA modulate their expression in a donor specific way. Our results
show that the inflammatory responses of macrophages can be chan-
ged by modification of PLA material surface. A monocyte-based in-vitro
system for testing individual responses to the implanted material was
established for selecting personalized implant variant.
Funding: IMMODGEL project, Grant No (602694).
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Objectives: Statistics shows that populations around the world are
highly sensitive towards meteorological factors. Vascular disorders re-
sult in a systemic imbalance, further, impairing adaptation to sudden
meteorological changes.
The research objectives are to find new personalized algorithms to
predict adverse health effects by meteorological factors and create
targeted preventive measures [1-3].
Technological approaches: Technological approach is focused on
establishing specific biomarker patterns reflecting individual reactions
towards changing meteo-factors such as atmospheric pressure, air
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humidity, air temperature, wind velocity and direction, magnetic
vibrations.
Results interpretation and Outlook: The results comprise the proto-
type of a portable meteo-station for self-monitoring and integrated
care. The developed device is applicable to several patient cohorts
such as those suffering from cardio-vascular and psychoneurological
disorders.
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The goal to provide individualized tailored treatment to patients in
terms of efficacy and adverse events depends on the ability to define
the "disease signatures". A term that became a premise in the thera-
peutic targets, precision medicine and disease prediction processes,
but depends heavily on the comprising, analysis and translation of
all relevant personal data. It may include all the micro- and macro-
factors of the human body functioning in its physical, mental and
community environment, such as age, gender, clinical tests, bio-
logical markers, lifestyle, medical history, genetics, imaging etc. The
new sophisticated and advanced technologies are enabling the cap-
turing of these parameters through profound insights on the human
body functioning, in various levels and degrees of sensitivity, providing
"Big Data" initiated from various sources. The goal is to analyze si-
multaneously all these identified and captured factors, including their
interplay, translated to "disease signatures" towards responsible person-
alized, preventive and predictive medicine applied in the clinics.
Thus, it creates the need to bridge barriers between "Big Data" and
"Small Data" such as the simultaneous analysis of different types of
data, sometimes related to a few number of people (many parame-
ters, few records) tackling over fitting as well as database leakage [1],
replicability [2] and reproducibility barriers. For example, hospital da-
tabases with limited availability of healthy records and different diag-
nostic tests undertaken by healthy and sick people, suffer from
leakage and replicability barriers.
Furthermore, other challenges are:
- Expert knowledge is valuable but current diagnosis might be misleading.
- Compensatory mechanisms, obscuring the linkage between bio-
logical markers (i.e. imaging, pathology and genetics) and disease
manifestation, are difficult to discover.
- Big Data: Big potential but increased chances of capturing irrelevant
markers.
Thus to address these challenges new technologies and targeted
tools are being developed, among them the "3C" strategy developed
in our group. The goal is to meet the growing sensitivity and specifi-
city needs in representing the medical data variance and its rele-
vance and contribution to personalized medicine.
The 3C- Categorization, Classification & Clustering- strategy,
developed as part of the Medical Informatics sub-project in the
Human Brain Project Flagship, is targeting to utilize and converge
the medical expert knowledge, the disease manifestations and
the potential biomarkers towards personalized prediction and
treatment.
The methodology includes the three steps: Categorization, Clustering
and Classification, based on supervised and unsupervised algorithms.
Step 1 - Categorization of variables into three types: (1) disease diag-
nosis as assigned in the electronic health record (EHR), by the
medical expert. (2) Clinical measurements reflecting the patient’s
condition and functionality. (3) Potential biological markers, (Pro-
teins, imaging, etc.) proposing predictive value for disease risk, de-
terioration or for severity. Step 2 - Feature selection and Clustering.
Following the categorization and feature selection of the clinical
measurements, an unsupervised learning creates sub-classes repre-
senting new disease diagnosis classes based on the differences in
the manifestation of the disease. Step 3 - Classification including
potential biomarkers. Given the homogenous clusters and following
a feature selection of the potential biomarkers, this step is seeking
for relations between identified potential biomarkers and each of
the homogenous clusters using hierarchical decision trees, or other
rule based analysis.
A preliminary feasibility study of the "3C strategy" was applied suc-
cessfully to the Alzheimer's disease Neuroimaging Initiative (ADNI)
cohort, identifying and suggesting 10 sub-classes, rather than the 5
assigned in the ADNI data set – AD (Alzheimer disease), EMCI, LMCI
(Early & Late Mild Cognitive Impairment), SMC (Significant Memory
Concern) and CN (Normal).
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Scientific objectives: The personal attitude to own body is undoubt-
edly correlated with the quality of life (QoL). Our recent study on the
influence of the lipodystrophy (cellulite) on the quality of life of
women showed that their quality of life is influenced by the skin
imperfection depending on the cellulite stage [1]. In the study group,
lipodystrophy according to the Nürnberger-Müller scale was diag-
nosed in 60 subjects. Te Polish version of The Brief Illness Perception
Questionnaire – B-IPQ was used for evaluation of the QoL [2, 3].
Currently, there is no reliable objective diagnosis of this kind of lipo-
dystrophy. In this paper, we propose to exploit the thermal imaging
for cellulite diagnosis. The superficial body temperature distribution
is influenced by many factors, among them the fat cells layer play an
important role.
Technological approaches: Our study is devoted to the validation of
the use of infrared thermal imaging for the assessment of cellulite
and to development of the objective method to evaluate the severity
of cellulite. Thermal images of the thigh were recorded and further
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processed to quantify the temperature distribution. 12 young women
(20-24 years old) with various degrees of cellulite were enrolled in to
the study. We developed our own application based on Java Tech-
nology, for importing and analyzing data from infra-red images. Our
new software (ThermaAnalyzer 2.0) is designed for assessment of the
degree of cellulite. It is based on an algorithm, which can search for
irregularities (blemishes) on thermal image. By analyzing the
temperature distribution of the examined part of body, it is possible to
diagnose the cellulite stage and thus, the influence of possible anti-
cellulite therapy.
Results interpretation: Our observations revealed that people with
higher degree of cellulite have more irregular superficial temperature
distribution seen as the spots on the thermal image. Thermal im-
aging can be an objective method for lipodystrophy diagnosis and
monitoring of therapy.
Outlook and Expert recommendations: Further studies in larger
group are required to elaborate the reliable diagnosis based on ther-
mal imaging. This can help to personalize the treatment, which
include the proper diet, cosmetics, physiotherapeutic agents and
physical activities.
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A high prevalence of secondary caries as well as difficulties in
verification of its stages set the problem of search for new approaches
to early diagnostics, prevention and treatment of the carious process.
Nowadays the development of high-tech methods of assessment
and treatment in dentistry raise requirements to the core elements
of White Esthetics, such as color, form, function, and material durabil-
ity. Numerous studies have shown that smaller particles of filling ma-
terial makes the esthetics better and facilitate gingival attachment
and adhesion that prevents from tooth-filling physical and chemical
disbonding and secondary caries occurrence. However, the microfilled
composites do not possess high strength properties which prevents
from using them in the areas of increased load and in chewing teeth.
The new direction in dentistry presupposes an enlargement of filling
material particles with its high esthetic properties reserved wherein
there is an increase in durability and elasticity. It is especially import-
ant because of frequent cases of cracks and chips in restorations
after treatment of teeth that carry increased functional load. A large
number of scientific researches made it possible to come to a conclu-
sion that the physical factors of therapy influence on the ultrastruc-
ture of filling materials in which there are changes in the substance
structure at the micro level, which positively effects on the strength
properties of the material. Teeth enamel has "enamel tunnels" and
"enamel bridges" which regulate exchange processes between en-
amel, dentine, oral liquid and filling materials.
It is essential to search for options of physical fields’ action on filling
materials, which, without affecting their esthetic properties, will en-
able to increase their durability and microhardness so that they be-
come more resistant to mechanical and physical effects that will
contribute to a longer lifetime of fillings. Thus, the provided data
allow making the conclusion about a variety and diversity of changes
occurring in a filling and in a tooth in the carious process develop-
ment, which predicts perspectives for carrying out further research in
the field of secondary caries prevention.
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The modern dentistry has a wide range of medicines for caries pre-
vention, but spreading allergization of the population requires the
development of alternative methods for dental diseases prediction.
Such preventive measures include different types of light radiation.
The purpose of our research was studying the LED radiation influ-
ence of the ULOХ device on the mineral exchange in tooth enamel.
A method of enamel acid biopsy according to Leontyev and Distel
offered the opportunity to determine the speed of acid solubility of
enamel calcium. The X-ray spectral microanalysis (RMA) allowed
studying the chemical pattern of the enamel surface layer with the
accuracy of 0.01 %. The equipment used: scanning electron micro-
scope CamScan S4.
Such factors as tooth extraction and its isolation from the saliva
reflected adversely on the level of enamel mineral exchange, which
consisted in increasing of acid solubility of enamel calcium by
30.13 % in a day after the tooth extraction, which is 7.66 μmol/min
more than the reference value. A reliable reduction of calcium by
20.3 % and phosphorus by 19.7 % was in parallel observed in the en-
amel surface layer. Even upon completion of the observations (in a
month), the results did not revert to the initial values.
We observed other dynamics of mineral exchange in the group of teeth
exposed to the LED radiation by the ULOX device: the speed of acid
solubility of enamel decreased by 23.11 % in a day after the radiation,
and the content of calcium and phosphorus increased by 11.63 % and
8.53 % respectively, which is more than the initial values by 3.19 and
1.01 % by weight respectively. And by the 4th week the studied indica-
tors did not differ much in comparison with the initial level.
The changes in tunnel structures and exchange processes stimulated
by light-induced radiation and with the use of ROCS medicines ac-
cording to our scientific data. Thus, the research data prove that the
LED radiation facilitates increase of calcium and phosphorus content
in the enamel surface layer and reduction in speed of enamel acid
solubility. This indicates the mineral exchange normalization as well
as a tooth enamel resistance and micro-hardness increase.
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Scientific Objective: The world-wide epidemic of diabetes mellitus,
and associated micro- and macro-angiopathic complications, is one
of the most pressing health-related challenges of our time. Indeed,
diabetic nephropathy is the leading cause of end-stage kidney disease
thereby requiring renal replacement therapy. This not only suggests in-
adequacy of current drug therapies but also failure of endogenous
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protective and reparative mechanisms. Abnormalities of the endothe-
lium constitute major pathogenic mechanisms contributing to the initi-
ation and progression of diabetic nephropathy. Endothelial progenitor
cells (EPCs) are of myeloid origin and capable of replacing injured
endothelial cells and differentiating into functional endothelial cells.
Thus, we explored the status of EPCs in animal models of diabetes mel-
litus, in the setting of nephropathy, and also determined whether the
diabetic milieu affects the survivability of these cells.
Technical Approach/Methods: Streptozotocin-induced type 1 diabe-
tic mice and obese type 2 diabetic db/db mice, and their appropriate
controls, were used for this study. Accordingly, indices of glycemic
status and kidney function were determined in the context of assess-
ment of the status of EPCs in peripheral blood and/or renal tissue. In
addition, we explored whether diabetic animals display greater apop-
tosis of EPCs.
Results/Interpretation: Type 1 diabetic mice displayed significant re-
duction in EPCs (Sca1+Ckit+CD31+ cells) in the peripheral blood
6 weeks after streptozotocin injection in association with manifes-
tations of diabetic nephropathy (e.g., proteinuria). Since type 2
diabetes mellitus accounts for the majority of diabetic cases, sub-
sequent studies were carried out in db/db mice and their db/m
controls. The db/db mice showed significant increases in insulin
resistance index and hemoglobin A1c in association with marked in-
crease in albuminuria but reduction in creatinine clearance in associ-
ation with significant increases in apoptotic and necrotic cell death
of kidney cells. The peripheral blood cells of db/db mice displayed
reduction in EPCs compared to those of db/m controls. Further, kid-
ney cells prepared from experimental groups also showed reductions
in EPCs. Using markers of EPCs and apoptosis we observed increased
apoptosis of EPCs in cells prepared from kidneys of db/db compared
to those of db/m mice. Collectively, the results suggest that apop-
tosis of EPCs likely contributes to eventual manifestation of renal fail-
ure in diabetes mellitus.
Outlook/Expert Recommendations: The observation of a similar pat-
tern of decline in EPCs in the peripheral blood and the kidney sug-
gests that monitoring of blood levels of EPCs may be predictive of
failure of their protective and reparative features. Further, strategies
aimed at reducing apoptosis of EPCs and “empowering” them
through genetic modulations could potentially serve as effective
strategies to prevent end-stage renal failure in diabetic patients.
A52
The status of glucocorticoid-induced leucine zipper protein in
salivary gland in Sjögren’s syndrome: predictive and personalized
treatment potentials
Mahmood S. Mozaffari, Jun Yao Liu, Rafik Abdelsayed, Xing-Ming Shi,
Babak Baban
Department of Oral Biology, College of Dental Medicine, Georgia
Regents University, Augusta, Georgia 30912, USA
Correspondence: Mahmood S. Mozaffari (MMOZAFFA@gru.edu) –
Department of Oral Biology, College of Dental Medicine, Georgia
Regents University, Augusta, Georgia 30912, USA
The EPMA Journal 2016, 7(Suppl 1):A52
Keywords: GILZ, Sjögren’s syndrome, Salivary glands, Inflammation,
Predictive personalized treatment potentials
Scientific Objective: The glucocorticoid-induced leucine zipper (GILZ)
protein is a pivotal player in mediating the anti-inflammatory ef-
fects of glucocorticoids. However, its status and role in salivary
gland inflammation and dysfunction in Sjögren’s Syndrome (SS) is
not established. Thus, we tested the hypothesis that SS is asso-
ciated with reduced GILZ expression and increased leukocyte in-
filtration thereby contributing to inflammation and cell death in
salivary glands.
Technical Approach/Methods: We utilized the non-obese diabetic
(NOD) mice, a model of SS-like disease, in association with immuno-
staining and flow cytometry-based studies. These studies were com-
plemented with in vitro studies whereby interleukin (IL)-23-treated
salivary gland cells were co-cultured with mesenchymal stem cells
(MSCs) which over express GILZ (MSCs/GILZ) or express the green
fluorescent protein (MSCs/GFP); IL-23 is known to increase generation
of pro-inflammatory cytokine, IL-17. In addit ion, we carried out immu-
nostaining of lower lip biopsy samples of human subjects without or
with a diagnosis of SS.
Results/Interpretation: Salivary glands of NOD mice displayed a) re-
duced GILZ expression, b) foci of inflammatory cell infiltrates includ-
ing T and B lymphocytes as well as M1 and M2 macrophages and c)
increased pro-inflammatory IL-17 but reduced anti-inflammatory
cytokine, IL-10. These changes were accompanied with increased
apoptosis and necrosis of salivary gland cells of NOD than control
mice. Further, IL-23-treated salivary gland cells displayed marked in-
crease in IL-17 which was reversed with MSCs/GILZ but not MSCs/
GFP. Importantly, lower lip biopsy samples of SS patients showed
marked reduction of GILZ but increased IL-17 immunostaining com-
pared to those of non-SS subjects. Collectively, the results are sug-
gestive of GILZ playing a role in inflammation and cell death in
salivary gland in SS.
Outlook/Expert Recommendations: The present study has estab-
lished the relevance and significance of GILZ as a novel predictive
and prognostic molecular fingerprint for SS. Further, assessment of
minor salivary gland GILZ expression could potentially be a more
sensitive approach to help with diagnosis of SS, at early stage of the
disease, than that based on leukocyte infiltration. Importantly, subse-
quent studies should establish whether treatment with MSCs/GILZ
ameliorates signs and symptoms of salivary malfunction of SS for
which effective treatment options remain elusive.
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Aim: VO2max represents limiting complex interaction of our pulmon-
ary and cardiovascular systems and oxygen utilization on cellular
level. It could be directly measured and/or indirectly predicted during
stress testing on bicycle ergometer.
Method: VO2max was directly measured during step-vise increased
workload on bicycle ergometer. The values of VO2max and
VO2max/kg were compared to the values of W170 and W170/kg
and Wmax and Wmax/kg and both regression equations and cor-
relation calculated.
Subjects: 2777 male (2015) and female (n = 762) subjects aged 7 to
95 years were included into the study. The highest correlation be-
tween maximal aerobic capacity values VO2max and VO2max/kg
was found to maximal performance in Watts (Wmax and Wmax/kg)
(r = 0.92). Regression equations enable to calculate predicted VO2max
and VO2max/kg with high accuracy. Figures 2 and 3 illustrate the cor-
relation between VO2max and Wmax in men and women.
Discussion: Maximal aerobic capacity has been strongly and posi-
tively associated with reduced disease and mortality risk, good qual-
ity of life, performance level, and functional ability. Regular aerobic
endurance exercise could reduce biological age of active individuals
by 10 to 20 years with a correspondingly decreased likelihood of be-
coming dependent when a senior and an expressive improvement in
the quality of the final years of life. However, low level of VO2max
and VO2max/kg indicates that serious health threatening problems
could be expected in near future.
Conclusion: Individual maximal aerobic capacity is an important mar-
ker of health status. Knowledge of VO2max and VO2max/kg could
help to prescribe optimal volume and intensity of physical activity to
every client asking for advice how to benefit from the altered life-
style. High correlation between predicted and directly measured
VO2max and VO2max/kg values enable low-cost examination of
these values in the framework of preventive check-up.
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There is a growing demand from patients to be better informed and
participate more actively in treatment decisions. Initiatives to give pa-
tients access to their data, such as patient portals, reflect a patient-
driven approach. The better informed patient is better equipped to
participate in the medical decision process, and the terms patient em-
powerment and shared decision making are often used in this connec-
tion. It has been shown that a better involvement of the patient leads
to an improved motivation to adhere to treatment, with better health
outcome. Many general practitioners are concerned that record access
will create more work, with extra consultations and telephone calls as a
result of patient misunderstandings. Studies suggest the opposite –
that record access can reduce resource demand. Both the European
Federation of Clinical Chemistry and Laboratory Medicine (EFLM) and
the Section of Laboratory Medicine of the UEMS (Union Européenne
des Médecins Spécialistes) recognize the development of patient em-
powerment and the changing role of care providers and patients. To
this end, the EFLM has established the Working Group Patient Focussed
Laboratory Medicine, which took the initiative of the current project [1].
The overall aim of the project is to design, develop and evaluate an
interpretative knowledge and reporting system that will inform pa-
tients so that they can comprehend the significance of their labora-
tory test results, enabling them to better participate in the shared
decision process with their physician.
The system developed by the ICT company Medecs represents a new
integrated approach to process the data from other healthcare sys-
tems and communicate the results in a flexible way to different
receiving systems and individual using several advanced types of
communication.
The project will help to reach a European standard in the transla-
tion of laboratory test information to information understandable
for patients.
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Preventing diseases of oral cavity, specifically periodontal diseases, is
currently a high-priority issue. Despite the wide selection of indi-
vidual oral care products and the abundance of information on indi-
vidual oral care, the prevalence of tooth decay and inflammatory
periodontal diseases remains high. Apart from knowledge of individ-
ual oral care, of great importance for patients is their capacity to
develop strong motivation for full-scale hygienic procedures. Pa-
tients´ motivation is immediately interconnected with their personal-
ity specifics. This article provides the analysis on the relationship
between the patient’s oral cavity status and his or her personality
profile.
Scientific objectives: Determine relationship between patient’s
personality traits and his/her oral cavity health status.
Technological approaches: The study was housed by the Therapeutic
Dentistry Department of the First Saint Petersburg State Medical Uni-
versity (SMU). A total of 153 people, 18 to 24 years of age, participated
in the study, with majority represented by students of SMU Faculty of
Dentistry, who went through identification of dental status – through
determining oral hygiene indexes (Green & Wermillion; Silness & Loe;
Fyodorov & Volodkina). The study also included determining the
gingival bleeding index (Saxer & Muhleman) and the papillary marginal
alveolar index (PMA).
Afterwards the patients were provided with professional hygiene,
individual oral care training, and recommendations on the use of
individual oral care products.
Fig. 2 (abstract A53).
Fig. 3 (abstract A53).
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In a month, the patients were invited for a repeated examination,
which included determination of dental indexes.
We developed a questionnaire to obtain information about the pa-
tient’s age, sex, social status, attitudes to his/her general health status,
and dental health. To identify personality traits of the respondents, we
performed a survey, which included the Leary test [1], Integrative Anx-
iety test (IAT) [2, 3], and Locus of Control test [4], Big Five test [5].
Results: As a result of the study, the patients were divided into two
groups: a negative dynamics group – with patients whose Green-
Vermillion index increased in a month, compared to the beginning of
the study; and a positive dynamics group – with patients whose GV
index decreased.
Each group was analyzed using the Spearman correlation coefficient -
r – for non-normal distributions. The analysis revealed weak positive
(0.4-0.7), weak negative (-0.7- -0.4), strong positive (0.7-1), and strong
negative (-1 - -0.7) correlation (р ≤ 0.01).
The following common factors were identified in the negative dy-
namics group:
1. Availability of the positive significant (р ≤ 0.01) correlation between
such indicators as:
 Saxer-Muhleman index and Locus of Control Scale 4 – in the
field of family relations
 Silness-Loe index and Leary 7 (cooperative style of
interactions), Leary 4 (distrustful style of interactions)
2. Availability of negative significant (р ≤ 0.01) correlation between
such indicators as:
 Saxer-Muhleman index and Locus of Control Scale 5 – in the
field of production relations (-0.41)
 Fyodorov-Volodkina index and Integrative Anxiety Test index
10 (phobic component of anxiety) (-0.42), Locus of Control
Scale 3 (control over misfortune) (-0.53), Locus of Control Scale
5 (in the field of production relations) (-0.56) , IAT 3 (-0.43), 7
(-0.44), 9 (-0.61)
 Green-Wermillion index and Integrative Anxiety Test index 4
(-0.47), 6 (-0.59), 10 (-0.45),12 (-0.41)
The following should be noted separately:
 Negative correlation relationship between frequency of dental
visits and Locus of Control Scale 3 (in the field of misfortune)
(-0.41)
 Attendance to preventive examinations and Leary index 1
(competitive style of interactions) (-0.54)
 Positive correlation relationship between attendance to
preventive examinations and Locus of Control Scale 6 (in the
field of interpersonal relations) (0.46)
 Negative correlation relationship between the tooth brushing
frequency and Integrative Anxiety Test index 10 (-0.41)
 Positive correlation between the frequency of tooth brush
replacement and Leary index 1 (competitive style of
interactions) (0.55), 2 (aggressive-independent style of
interactions) (0.47), 8 (responsible-altruistic style of interactions)
(0.63), Integrative Anxiety Test index 2 (0.46)
 Negative correlation between the frequency of tooth brush
replacement and Locus of Control Scale 6 (in the field of
interpersonal relations) (-0.40)
 Positive correlation between the use of a tooth brush and
mouthwash and Leary index 6 (dependent and obedient style
of interactions) (0.41)
 Negative correlation between the right manner of cleaning
teeth from the patient’s perspective and Leary index 1
(competitive style of interactions) (-0.41), 2 (aggressive-
independent style of interactions) (-0.47)
In the positive dynamics group, the analysis only revealed correlation
between hygienic and periodontal indexes.
Outlook: In the group with high oral care rates, no psychological
specifics were identified. This may be indicative of the fact that
the relationships between the good oral cavity health status and
the patient’s psychological type were not formed, or were not
manifested.
In the negative dynamics group, the following common factors were
identified:
There is positive correlation between oral hygiene indexes and
frequency of dental visits: the worse the oral hygiene, the more
frequent the patient’s need to attend a dentist.
There is positive correlation between hygiene indexes and the use of
additional hygiene products, and there is negative correlation be-
tween hygiene indexes and the use of only a tooth brush, which is
indicative of the patient’s need in additional hygienic products in
case of increased plaque-forming.
Inverse correlation between oral hygiene indexes and trait and state
anxiety in the field of production relations (Locus of Control Scale 5),
may be explained by the patient’s low level of responsibility for his/
her work and oral care.
There is positive correlation between Silness-Loe index and Leary
index 4 (skeptical and distrustful style of interactions), which shows
that people of this type of interpersonal relations distrust doctors
recommendations on oral care.
Patients with low level of anxiety replace toothbrushes less frequently.
Patients with low figures of Leary indexes 1, 2, and 8, which correspond
to competitive, aggressive-independent, and responsible-altruistic
styles of interactions respectively, are less careful about their health.
Patients with low Leary index 6 (dependent and obedient style of in-
teractions) do not follow doctor’s recommendations properly.
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Scientific Objectives: The implementation of personalized medicine
will imply a significant increase in the number of performed
screening or diagnostic tests and a larger volume of data to be
gathered, analyzed, and translated into information to serve as
guidance for clinical decisions. Laboratory medicine is asked to
play a key role in the personalized medicine approach; however, it
is not clear if this development is shared by the laboratory
medicine directors and if/how some activities have been already
planned at the local or national level to reach this goal.
Technological approaches: To investigate whether laboratory
medicine is able to implement new diagnostic tools, expertise and
commands, and the proper state-of-the-art knowledge about
personalized medicine and laboratory medicine in Europe, the joint
working group “Personalized Laboratory Medicine” of the EFLM
(European Federation of Clinical Chemistry and Laboratory
Medicine) and ESPT (European Society of Pharmacogenomics and
Personalised Therapy) societies compiled and conducted the
questionnaire “Is Laboratory Medicine ready for the era of Personal-
ized Medicine ?”.
Results interpretation: Forty-eight laboratories from 18 European
countries participated in this survey. The answers of the participating
laboratory medicine professionals indicate that they are aware that
personalized medicine can represent a new and promising health
model, and that laboratory medicine should play a key role in sup-
porting the implementation of personalized medicine in the clinical
setting [1,2].
Outlook and Expert Recommendations: Participants think that the
current organization of laboratory medicine needs additional/rele-
vant implementations such as (i) new technological facilities in -
omics; (ii) additional training for the current personnel focused on
the new methodologies; (iii) incorporation in the laboratory of new
competencies in data interpretation and counselling; and (iv) cooper-
ation and collaboration among professionals of different disciplines
to integrate information according to a personalized medicine
approach.
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Proposed techniques: Speech disorders are one of the most com-
mon symptoms of different neurological diseases. It is obvious that
the early diagnosis of these diseases could help the patient to
slower the disease progression and start an intensive therapy on
time, which could also help with patient social recovery. The pre-
dictive techniques for early dementia or speech based diagnosis of
MCI patients were introduced in recent years. We propose to evalu-
ate the speech recordings from several simple predefined tasks
with subsequent automatic analysis using already tested scenarios
in [1]. The patient voice answers could be automatically analyzed
using methods from [2] and [1]. The textual analysis can be evalu-
ated using several algorithms reported in [3] or [4]. The combined
textual and prosodic analysis is presented in [5].
Using these methods the MCI patients can be currently diag-
nosed with 20 % EER (Equal Error Rate) and AD patients with
13 % EER [1], which should be decreased during the proposed
evaluation period using novel speech feature manipulation tech-
niques invented in our laboratory and extending the speech
patient DB in cooperation with our international medical
partners.
Widely used mobile devices equipped with microphones can be
also used for early speech-based digital diagnosis. Implementa-
tion of speech analysis algorithms with adaptation function for
individual user can be a part of personalized digital medical
assistant.
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Proposed solutions: This proposal is a description of our planned
participation as a technical partner in H2020 project named iManage-
Prenatal for speech/voice related human machine interaction (HCI)
components. The existing server based speech recognition module
will be used as starting point [1]. We aim to create a new acoustic
multilingual drug name database providing speech input for speech
based management of drug prescription recommendation during
pregnancy [2, 3]. We also plan to create a new multilingual speech
command interface providing eHealth mobile application functional-
ities for visually impaired end-users. The last proposal is to provide
multilingualism for automatic transcription of speech search query to
text for smart search in the knowledge base of the eHealth portal.
The last proposal includes the design and implementation of a
Natural Language Processing (NLP) Text Analyser of textual quer-
ies semantics expressed by the end-user [4]. The NLP module will
benefit from semantic knowledge extracted and stored in the
drug databases provided by the project partners. The database
analysis should go beyond the simple syntactical parsing of
grammatical structures.
The advantage of the proposed system is that the language
resources used for decoding the audio stream on the server side can
be modified by the provider without any changes on the mobile
application, so the feedback gathered during the application lifetime
can be used to improve the accuracy of the components in a very
short time, and without necessary end-user application upgrade.
These goals require multilingual acoustical modelling cooperating
with all partners’ countries. The adaptation of the end user model
could help to personalize the application for specific needs and
speech articulation.
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Despite a huge progress in modern oncology, advanced cancer re-
mains poorly treatable disease and the majority of patients with ad-
vanced tumors eventually die. In the current era of personalized
medicine the optimal choice of therapy depends upon the detailed
analysis of the cancer genome and identification of the targetable
mutations for each individual patient. Substantial limitation of this
approach stems from the considerable spatial and temporal intratu-
mor heterogeneity of advanced disease. The direct tumor biopsy re-
mains for a long time the standard-of-care for verification of cancer
type and for analysis of targetable mutations. However, the vast tem-
poral and spatial tumor heterogeneity would virtually require mul-
tiple biopsies from primary tumor site as well as distinct metastases
at different time points. This is not generally feasible because of poor
medical condition of advanced cancer patients, possible clinical risks
and surgical complications and also economic considerations. To
overcome these limitations there is a big effort to implement novel
minimal-invasive or non-invasive methods to analyze individual pa-
tient’s tumor biology and heterogeneity. One of these approaches
utilizes circulating tumor cell-free nucleic acid (cfDNA) in the blood
as well as cerebral spinal fluid, urine and other body fluids of cancer
patients, so-called liquid biopsy. The liquid biopsy techniques offer
unique opportunity to asses and monitor complex cancer disease in
individual patient in a real time. In the near future, the liquid biopsy
likely becomes a standard of care for early detection of the disease,
assessment of molecular heterogeneity and prediction of best tar-
geted therapy, evaluation of treatment response, monitoring residual
disease together with the early detection of recurrence or assess-
ment of resistance to given therapy.
This work was supported by MH CZ-DRO (Faculty Hospital in Plzen-
FNPl, 00669806) and the project ED2.1.00/03.0076 from European
Regional Development Fund.
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Background: Stroke care in Czech Republic is centralised to stroke
centres. Stroke centre University Hospital Plzen provides acute
stroke care for 600 000 habitants of West Bohemia. Providing
and sharing information on stroke is useful tool for improving
stroke care.
Summary of work: Optional one-day course “Complex stroke care for
medical students“ in our Faculty of Medicine is additional part of
standard pregraduate courses of neurology since 1999. Special edu-
cational programme “Complex stroke care for nurses and para-
medics” is another activity of our stroke centre. This programme
started in 2001 as two-day course, updated and certified by Ministry
of Health of the Czech Republic in 2009. Duration of course is now
9 days divided in two parts. First (3 days) – includes lectures and
discussions on main topics – pathophysiology of stroke, diagnostics
and imaging, stroke treatment, thrombolysis, mechanical recanalisa-
tion, neurosurgery, stroke and heart, stroke and diabetes, neurointen-
sive care, speech problems, complications of stroke, depression,
primary and secondary prevention, nursing, specificity of care for
stroke patients, communication with patients and caregivers, legisla-
tion and regulatory, stroke care organisation, physiotherapy and
occupational therapy, social assistance, ethics, education. The second
part (6 days) – practice mainly in Stroke Unit and Physiotherapy
Department.
Summary of results: 1120 medical students completed the optional
course. 493 nurses, occupational therapists and paramedics from the
whole country completed the special educational programme on
stroke care. The course quality evaluation (usefulness, complexity,
importance in daily practice) by participants is high (9.2 out of 10
points).
Conclusions: Multidisciplinary educational programmes for medical
students as well as for nurses and paramedics consisting of lectures,
discussion and practical training are useful and bring new quality to
stroke care.
This work was supported by MH CZ-DRO (Faculty Hospital in Plzen-
FNPl, 00669806).
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Sleep apnea is a frequent disturbance with prevalence of 3-4 % in
adult man [1, 2], and is 2-9 times more prevalent in men than
women [3]. The most prominent symptoms of sleep apnoea are
intermittent breaks of breathing in the night (apnea) which causes
general hypoxia and daily sleepiness. Risk factors for sleep apnoea
are vascular hypertonia, smoking, obesitas, Diabetes mellitus and age
[4]. The consequences of sleep apnea are cardiovascular diseases in-
cluding heart infarctation and brain apoplexy, as well as depression
and cognitive decline. The diagnosis of sleep apnea can be made by
polygraphy and/or polysomnography recording in sleep labor ac-
cording to the following criteria: more than 10 apneas in one hour of
sleep, each with duration longer than 10 seconds.
The reason for cognitive decline in patients with sleep apnea is the
intermittent hypoxia which causes disturbances of memory, attention
and learning [5-8].
According to actual studies, hypoxia causes cellular damage of left
hippocampus area which is one of the key brain areas for the cogni-
tion and memory [9-11].
But not only hypoxia as result of apneas can induce cognitive de-
cline, also the fragmentation of sleep by frequent awakening caused
by intermittent apneas impairs the consolidation of the memory es-
pecially in the REM (Rapid eye movement) sleep stage of the sleep.
Sleep apnea and sleep fragmentation can be significant factors for
brain aging causing severe disturbances of the cognition through
hypoxia of the brain and hyperarousals (stress).
Sleep apnoea and sleep fragmentation in elderly correlates with cog-
nitive decline both in the fluid and crystal intelligence. Those elderly
having sleep apnea and frequent sleep fragmentation are on risk for
cognitive decline. Healthy elderly with good sleep have good cogni-
tive reserve and delayed brain aging.
Early prevention of sleep apnea can probably protect from early
brain aging.
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Excessive fatigue and sleep disturbances caused by shift work can lead
to reduced work performance, processing errors, and accidents at work
[1, 2]. Sleep disturbances among shift workers can cause absenteeism,
reduced quality-of-life, and depression and rotating shifts can be a risk
factor for different somatic and psychiatric diseases as f.e. cardiovascular,
gastro-intestinal, metabolic, reproductive and malignant diseases [3, 4].
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There are general recommendation for some coping strategies
against sleep disorders associated with shift work, such as napping
and exposure to bright light [5]. Still more evidence is needed for
the individual approach to chronic primary and comorbid insomnia
in shift worker using cognitive-behavioral techniques. These individ-
ual and personalized coping strategies based on the sleep habits of
the shift worker should be considered in the workplace health pro-
motion programs of each work environment.
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The lifestyle of modern citizens is changing constantly: if they want
to be in the epicenter of professional, scientific and cultural events –
they need to travel. From the other side, people need qualitative rest
after stressful and intensive work. Up-to-day tourism is phenomena
of XXI century, sphere of extremely growing industry that creates
about 10 % of world gross product, attracts investments and involves
millions of people from different professions and qualifications into
its infrastructures. This sphere is scientifically-based industry, compli-
cated policy of global level, dialogue of civilizations and cultures. It
has a lot of directions: ecotourism, cultural, sport, special event and
scientific tourism; agricultural tourism, social tourism, etc. The med-
ical (health and wellness) travel, using the factors of nature, play an
important role for keeping up healthy lifestyle, preventing diseases;
activating the intrinsic bio-resources of the body and increase quality
of life after or together with treatment.
The impact of travel on medicine and economic development is un-
deniable. Medical and health travel follow the same aim – health im-
provement of the person, but they need different infrastructural
offers and personalized approach. Medical (rehabilitation) travel has
to be included into 3-level health care network: polyclinic – hospital –
health resort/rehabilitation center. In this case, the patient needs the
specific personalized treatment/care in specified profile departments
(respiratory, cardiovascular, musculoskeletal, neurodegenerative, etc.)
and inclusion of natural aero-, hydro-mineral, hydro-thermal, climate-
landscape resources. Doctors may recommend personalized accom-
pany programs for patients after treatment. In the case of healthy
travel, “practically health patient” have motivation to improve of health,
quality of life and have proper leisure time as well. Resorts in this case
have more possibilities for integration of natural resources with SPA-
programs and personalized preventive educational programs. Today
we need serious scientific-based coordination between tourism services
and medical health care system.
The direction of personalized medicine is dynamically developing
sphere in public health care system and medical science that enables
to predict individual predisposition before onset the disease, to pro-
vide targeted preventive measures and create personalized treat-
ment algorithms tailored to the person [1, 2]. For realization of this
purpose EPMA is promoting the advancement of multidisciplinary
approach, dissemination of knowledge and involve a lot of different
professionals and scientists for organizing new infrastructures - in-
novative clusters. Innovative clusters in PPPM and Medical Travel
under one umbrella have to create common advanced educational
programs [3], research centers, centers for transfer of scientific tech-
nologies and presenting the best practices, co-working centers for
co-using of scientific equipment [4]; public health organizations, fi-
nancial institutes, centers for development. All those centers have to
involve specialists from medical, economical, touristic, informatics,
other spheres to coordinate activities in economics of health and
market-oriented products: PPP – programs, passport of health, e-
medicine projects.
Several organizations were created under EU Commission support
for helping in the informational, educational, communicative devel-
opment, marketing and promotion: European Cluster Policy Group,
European Cluster Innovation Platform. New innovative medical and
travel cluster have to create new integrated information database,
supported with specific software and prepared in accordance with
international Standards (IFRS 8, USALI, USFRS).
Integration of medical travel services and PPPM specialists is actual
challenge for new strategies: we need the common database for bet-
ter coordination PPPM programs with travel offers, for better devel-
opment, for social responsibility in front of our patients and nature
resources.
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Actuality: Travel for health and beauty has become one of the main
trend of medical travel for women. Ecological problems and stress
motivate citizens combine their vocation with health travel to eco-
destinations. Resorts with natural factors (thalassotherapy, mineral-,
thermal- resources) and anti-aging-, anti-stress-, functional unloading
diet-, weight control, detox- programs are the most popular at the
health/medical travel market.
The problem of the endo-ecological crisis, toxication of the extracel-
lular matrix and immune deficiency are being discussed by leading
specialists of different branches of medicine. Practically, we can es-
tablish the new specific epidemic of endo-ecological disease, different
clinical forms of which are realizing in numerous nosologic variants. In
the case of the pollution of intercellular space and poor lymph circula-
tion, delivery of nutrients and oxygen into cells is broken. The risk of
development of inflammatory, degenerative, oncological processes is
raising. Accumulation of non-eliminated products in the interstitial
space is supposed to become the grain for development of specific
pathological processes, early aging, decreasing of a life quality and a
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chronic fatigue syndrome. So, medical examination, creation of the
personalized profiling protocols and algorithms (indications, contra-
indications) for healthy individuals and patients with endo-ecological
disorders to avoid the side-effects after treatment is actual problem for
medical travel, including SPA-, wellness-centers and resorts.
New protocol of investigation to identify the symptoms, signs and
markers for poor and retrograde lymph flow may help the doctors to
choose the correct health program, sequence of the procedures in
the women programs.
Clinical examination - postural tests and kinesthetic tests for “endo-
ecological crisis” are necessary for identification the role of the biome-
chanical disturbances in the upper aperture of the chest and myotonic
“tunnel-syndromes” in the cervical spine for affecting the state of
lymph circulation [1]. Test for fascia kinetics is: edema, congestion,
increasing of tissue density, the skin fold mobility restriction in sub-
clavicular and axillary areas.
The scheme of soft-tissue correction is aimed to remove the mechan-
ical obstacles for the lymph outflow to the main sub-clavicular collectors,
release the spasmodic muscles and activate the intersticial metabolism.
Relaxation of pectoralis muscles and adductors of the shoulder for re-
moving the compression of the lymph duct as well as relaxation of the
respiratory diaphragm have to precede to all the procedures in weight
control programs (classic lymphatic drainage, mud application, massage
treatments, etc.) to avoid side-effects for mammary glands.
Conclusion: Travel for health and beauty have to be supported and
guaranteed by the competent staff at the SPA-, wellness centers, re-
sorts with personalized programs (anti-stress, anti-aging detoxifica-
tion), including complementary medicine.
Endo-ecological problems and overloading of the lymphatic (immune)
system are the criterions for immediate restoration of the lymph circu-
lation in the treatment protocol.
Development of new approach to health and life-quality biomarkers
(“corridor of self-regulation”) and biomarkers of predisposition to
non-communicable diseases is the main task for PPPM and EPMA in
the field of medical travel.
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of education
Currently, we frequently face a generation gap problem in education.
In the majority of cases, older more experienced generation teaches
young people (students) which are significantly younger. There is no
doubt that it provides an excellent scientific base and forms basic
thought conception grounded on a long term experience of the
older generation. At the same time, it must be admitted that the less
the age difference between a teacher and a student is, the fewer bar-
riers occur between them. Moreover, it provides a proper material
perception and helps to avoid inconvenience in discussion.
All these facts lead to emergence of a concept which implies gradual
structure at formation of education concepts. It means that a profes-
sor, a doctor, a resident, a student and a pupil are involved in the
educational process. Such a concept helps to build bridges between
the older and the younger generations.
The same conception was applied in the reconstructive surgery
course. For the pupil it is barely possible to define the sphere of
professional interests at the young age. At the same time the sooner
the pupil starts to determine his professional interests, the higher his
professional results might be in the future. In case the teacher is sev-
eral years older than the student. It gives an opportunity for the
teacher to explain all aspects of his work easily, openly and to re-
ceive a maximal feedback.
This concept was also applied in our workgroup. All required infor-
mation represented in a simple and available format by means of
student’s work presentation on a school basis. The pupils can directly
communicate with project participants and probably become a part
of the workgroup. They receive an opportunity to work with people
who have just been in a status of a pupil.
Communication of the students and postgraduates is based on the
same principle.
In our opinion it is time for the education reform. The main goal of
this reform is hierarchy orientation in different generation’s commu-
nication. This orientation gives grounds for the professional merits
upgrade and lessening of negative impact in case of professional
interest uncertainty.
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Scientific objectives: Stroke is one of the most frequent causes of
death and disability. 20-40 percent of patients suffer from a recurrent
stroke [1]. Causes are unclear etiology (cryptogenic strokes) and a
lack of adherence in the treatment of risk factors such as hyperten-
sion and atrial fibrillation. The improvement of AF detection in
cryptogenic strokes and monitoring of vital parameters in order to
get and keep patients within therapeutic range therefore are essen-
tial. The APOOWL project was designed to test if this can be
achieved by telemonitoring.
Technological approach: For the detection of AF in patients with
cryptogenic stroke 41 patients received a holter ECG that submitted
ECGs via GSM to the telemedicine center on a daily basis. 70 patients
received a blood pressure device that submitted systolic and diastolic
blood pressure values to the telemedicine center twice daily. 29
patients were monitored for INR values. All data were automatically
integrated into an electronic patient file and evaluated by the cardi-
ologist of the telemedicine center.
Results interpretation: In 6 patients with unknown history of AF acute
episodes were detected. The detection rate of 15 percent corresponds
to those of trials with implantable loop Recorders. Average detection
time was 50.5 days (range 9 to 112). Average blood pressure values of
patients have been reduced from 136/80 to 124/73 within 9 month.
The reduction by 12/7 mmHg corresponds to a risk reduction for recur-
rent stroke by at least 36 percent [2]. In INR management time within
therapeutic range was 75.27 compared to regular care between 58 und
68 [3].
Outlook and Expert recommendation: Telemonitoring can signifi-
cantly reduce risks of recurrent stroke. Limitations of the trial are fairly
small numbers of patients and lack of control group which was due to
limited time and resources. Larger randomized trials also including pri-
mary prevention are recommended.
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Women’s increasing breast cancer rates and female-male gap in
cancer incidence/mortality with western diet, specifically with n-6
polyunsaturated fatty acid (PUFA) consumption, raised questions
regarding ‘gender nutrition’- related health differences with the
same diet, and implications for personalized nutrition. High n-6
diets, e.g. the Israeli diet – close to the Mediteranean diet and to
recommendations, save for higher n-6 (≤12%kcal) – have been
associated with women ranking much worse internationally for cancer
mortality, all-cancer 15th vs. men’s 37th/44 countries and 13th vs. men
2nd-best/22, and breast, +19.2 % above a European 27-country average
vs. prostate -30.4 % below; and much smaller gender differences, i.e. in
female-male life expectancy, -31.6 % vs. European average, and male:fe-
male mortality ratios for all-cancer -27.1 %.
Ethnic comparisons revealed consistently higher cancer prevalence in
Israeli-Jewish than Israeli-Arab women, though Arabs’ recently in-
creased 3.0-fold more rapidly, gradually closing the ethnic gap, concur-
rent with their increased n-6 intake, as corn/soy oils replaced
traditionally predominant olive, while Jewish n-6 consumption declined
(12 to 8.8%kcal [1995-2001]), though recent Jewish intake was still
+25.5 % and n-6:n-9 monounsaturated fatty acid ratio +40.4 % higher.
Cumulative research has shown females’ greater PUFA conversion,
especially n-6 linoleic-acid (LA) to arachidonic acid (ARA) and to the
related inflammatory/mutagenic/carcinogenic n-6 eicosanoid cas-
cade. Estrogen's mechanistic/molecular oxidative interactions with
ARA, showed further effect on DNA-adduct formation, depurination
and damage. This is beyond estrogenic effects through hormonal-
metabolic cascades, suggesting causal relationships between high n-6
intake, estrogen, and breast cancer, which could exacerbate other risks,
including genetic predisposition, i.e. BRCA and Her2, obesity, metabolic
syndrome, pre-/diabetes, and the effect of life event-related predispos-
ition – including early menarche, late childbearing and breastfeeding –
emphasizing the importance of gender-specific nutrition in primary
and secondary cancer preventive/supportive strategies.
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The recent epidemiological findings reveal a high prevalence of peri-
odontal diseases. Thus, 60-70 % of individuals aged 20 already have
gingivitis and periodontitis, and the prevalence of the diseases, espe-
cially in the case of the latter, reaches 100 % in 35-45-year-old adults.
Most periodontal diseases are first diagnosed using different visual,
instrumental or radiological procedures. A number of adverse events
occurring in the course of periodontal disease development, such as os-
seous tissue destruction, are extremely difficult to treat, which, in turn,
highlights the importance of periodontal diseases prevention. Given the
significance of early detection of such-like diseases for further effective
treatment, it is impossible not to note a high diagnostic potential of the
gingival crevicular fluid (GCF) in detection of various periodontal dis-
eases. Our investigation has summed up the available data on using
the GCF markers to detect periodontal diseases at early stages.
We examined 120 individuals of both sexes aged 18 to 25 and ana-
lyzed the cytobacterioscopic, hygienic and clinical findings as well as
different GCF markers. The results have shown that the early stages
of the inflammatory process are characterized by the growth in the
number of cocci forming a kind of clumps, the formation of pseudo-
mycelium of yeast cells chains up to 8-10 per high power field as
well as not quite mature epithelial cells with a nucleocytoplasmic ra-
tio of 1:2. The analysis of the enzymes that may be found in the gin-
gival crevicular fluid detected that levels of Alkaline Phosphatase
(ALP), the enzyme involved in periodontal tissues destruction, vary
greatly in healthy individuals, patients with gingivitis and patients
with periodontitis. It should be also noted that an increase in the en-
zyme levels is associated with the activity of bacteria with a highly ac-
tive Alkaline Phosphatase (such as Prevotella intermedia, Streptococcus
sanguis, Porhyromonas gingivalis) and the increase in the number of
polymorphonuclear leukocytes. This brings us to the conclusion about
the priority of bacterioscopic and cytological changes in the gingival
crevicular fluid as the earliest markers indicating periodontal abnormal-
ities, which makes it possible to suggest high efficiency of the cytobac-
terioscopic investigation carried out to detect the initial stages of
periodontal diseases according to Prof. A.A. Kunin’s approach.
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Aesthetic aspects of dental treatments create the emerging field for both
producers and clinicians in view of permanently increasing patient re-
quests [1, 2]. Dental caries is still the most prevalent disease as it affects
up to 100% of adults. By now, all methods of the treatment of caries are
highly invasive. They include the invasive removal of tooth substance
with the subsequent restoring of the tooth using the direct or indirect
methods. The basic material for the direct restorations is composite.
However, the composite restoration besides indisputable advantages
has a significant drawback – the low service life and the need for re-
placement of the restoration. Clinical application of the pre-polymerised
forms of composite was the qualitative breakthrough in this issue [3,4].
In this study, 274 restorations were carried out. 130 restorations were
carried out by using the standard form of composite and 144 restora-
tions – by using the pre-polymerised form of composite. The follow-
ing personality parameters of each restoration were taken into
account in this research: Ryge criteria, hygienic index, index of the
hard tissues destruction, intensity of the caries, the age, the vitality
of the teeth, and the number of previous invasions.
During the analysis of the results of statistic proceeding by the
method of cluster analysis the following data were discovered: the
quality of treatment immediately after the restoration in the group of
pre-polymerised composite was 5.52 times (p ≤ 0.05) higher than with
the standard forms, and after 12 months of treatment – 6.45 times
higher (p ≤ 0.05). The results of statistical processing conducted by
using the associative neural network ("artificial" intelligence) have
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shown that the accuracy of matching the predicted and clinical re-
sults was 80.01% in both groups of patients. The programme
predicted the condition of the restorations after 12 months in-
dividually for each restoration and compared the results of pre-
diction with objective data obtained experimentally.
High accuracy of forecasting can help the practitioner during the stand-
ard check-up procedure after 3-4 weeks of the treatment to predict the
condition of the restoration after 12 months and make the correction
of the restoration with minimally invasion for preventing the excessive
loss of dental hard tissue and re-psychological trauma of the patients.
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National eHealth System, covering all citizens and all healthcare levels
in Republic of Macedonia, was introduced in July 2013, has been inter-
nationally recognized System for successful reduction of waiting times
and instrumental in the management of national healthcare resources.
For the first time, National Diabetes Committee, formed in February
2015 according to the Law on healthcare and being overall respon-
sible for the diabetes care in the country, was able to derive exact
figures on the national diabetes prevalence from the System, instead
of extrapolations used before, serving as a basis for development of
strategies for prediction and prevention of diabetic complications, as
well as for personalized diabetes care.
Number of diabetes cases identified through the National eHealth
System in June 2015 was 84,568 (4.02 % of total population), 36,119
males (3.42 % of total male population) and 48,449 females (4.61 %
of total female population). Age stratified diabetes prevalence was as
follows: less than 20 years – 549 cases (0.11 % of respective popula-
tion), 20-39 years – 3,202 (0.49 %), 40-59 years – 26,561 (4.58 %), 60-
79 years – 48,470 (14.57 %), 80 years or more – 5,786 (12.96 %).
Addition of parameters for metabolic control and diabetic complica-
tions in the System is under way, further facilitating the modeling of
diabetes treatment, metabolic control and the outcomes. Inclusion of
pre-diabetes patients (IGT and IFG) is also planned, thus providing
opportunity to also focus healthcare activities for prevention of pro-
gression into overt type 2 diabetes.
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Scientific objectives: The impairment of the muscle functions by dis-
eases not usually confined to muscular tissue, are a frequent cause of
consultation. Weakness, pain, cramps, rigidity, loss of muscular control,
myoclonus (twitching, spasming) and myalgia (muscle pain) are
common symptoms of muscle disease. The main sequences of events
during muscle contraction are the binding of ATP to the S1 unit (the
catalytic unit of myosin), and the immediate reaction producing ADP
and Pi provides the free energy to move the S1 unit into the strained
position. ADP and Pi remains attached to the S1. Myosin is an enzyme,
specifically an ATPase [1]. Myosin S1 works like other enzymes but
the conformational change is magnified. Shortening requires ATP
hydrolysis and myosin binding to actin is essential for rapid ATP
hydrolysis.
However, this happy and simple explanation is contradicted by some
interesting observations: Relaxed muscle has low ATPase activity as if
myosin does not bind to actin. Relaxed muscle is easily extensible
(low stiffness) as if myosin does not bind to actin. Furthermore, nei-
ther myosin nor actin is contractile [2]. The free energy of the system
drops in contraction. The relaxed state is the high-energy metastable
state, and the contracted state the low energy stable state [2].
By other side, ATPase activity is bound up with myosin, but only a
very small fraction of myosin molecules are endowed with such ac-
tivity. Thereby question remains how the energy liberated by a mol-
ecule can be communicated to a great number of similar molecules.
The common energy levels give an easy answer [3].
The unraveling of the intrinsic property of melanin to transform light
energy into chemical energy through the water dissociation [4] fits
very well with the common energy levels of Prof. Szent-Gyorgyi.
Results interpretation: Relaxed muscle is a molecular state ordered
than a contracted muscle; therefore more order requires more
energy. This is almost impossible to explain if we thought that
glucose and ATP is therefore a source of energy. The finding that
melanin transforms light energy into chemical energy by means of
the dissociation of the water molecule, releasing hydrogen diatomic
and high-energy electrons, breaks the paradigm and lays the
biochemical foundation of the concept of the Prof. Szent-Györgyi
about common energy levels.
Outlook and Expert recommendations: Understand that the relaxed
muscle is a state of energy higher that a contracted muscle opens a
new scenario in the study, diagnosis, and treatment of muscle disor-
ders. It is shocking to understand that a contracted muscle repre-
sents one energy level less than a relaxed muscle. Understanding the
true nature of muscle means to better understand health and disease
of the same, which allows a better medicine preventive, predictive
and personalized.
References
1. Engelhardt WA, Ljubimowa MN. Myosine and Adenosinetriphosphatase.
Nature. 1939;144:668-9.
2. Szent-Gyorgyi A. Free-energy relations and contraction of actomyosin.
Muscular Contraction. Acad. Press, New York, 1947.
3. Szent-Gyorgyi A. Towards a new biochemistry? Science 1940;93(2426):609-11.
4. Solís-Herrera A, Arias-Esparza MC, Solís-Arias RI, Solis Arias P, Solis Arias MP.
The unexpected capacity of melanin to dissociate the water molecule fills
the gap between life before and after ATP. Biomed Res. 2010;21(2):224-6.
A72
Plurality and individuality of hepatocellular carcinoma: PPPM
perspectives
Krishna Chander Sridhar, Olga Golubnitschaja
Department of Radiology, Univeristy of Bonn, Bonn, Germany
Correspondence: Olga Golubnitschaja
(olga.golubnitschaja@ukb.uni-bonn.de) – Department of Radiology,
Univeristy of Bonn, Bonn, Germany
The EPMA Journal 2016, 7(Suppl 1):A72
The EPMA Journal 2016, Volume 7 Suppl 1 Page 34 of 42
Keywords: Predictive preventive personalized medicine, Innovative
screening methods, Patient-specific therapy, Multilevel diagnostics,
Molecular markers, CTCs and CNAPS, Stratification
Hepatocellular Carcinoma (HCC) may arise due to various risk fac-
tors such as genetic predisposition, chronic hepatic infections, al-
cohol abuse, hemochromatosis, cirrhosis, obesity, fatty liver
disease, etc. [1, 2]. Low mean 5-year survival rate (15 %) and high
treatment costs imply the need for more effective treatments tai-
lored to the person [3]. The predictive, preventive and personal-
ized medicine (PPPM) aims at paradigm change in management of
HCC from delayed to advanced approaches creating innovative
screening programs, early/predictive diagnostics and targeted
therapy [1]. For that, better patient stratification is needed utilizing
multilevel diagnostics. Molecular mechanisms which underlie
tumor manifestation, progression and aggressiveness may vary
substantially in HCC depending on a number of factors such as
localization of the primary tumor, tumor’s characteristics / sub-
type, family history, life-style and co-morbidities. Consequently, a
creation of individualized patient profiles is of particular import-
ance in patient stratification, predictive/early diagnostics and tar-
geted treatments of HCC (see Fig. 4). Further, highly sensitive and
specific biomarker-panels play a crucial role in sub-categorization
of HCC, e.g. to distinguish between local and distanced metastatic
activities, where the latter are functionally linked to circulating en-
tities such as circulating tumour cells (CTC) and circulating nucleic
acids in plasma and serum (CNAPS) [4].
The integrative PPPM-strategies advancing HCC management (both
curative and palliative) may have great impacts on improved screen-
ing of individuals at risk, life-quality of targeted patient cohorts, bet-
ter healthcare economy and benefits to diagnostic and
pharmaceutical industry.
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Background: This research elucidates the creation of new trends in
medicine and biopharmacy using the latest achievements in basic
sciences and high technology areas, as well as the development of a
concept and thus the strategy for deeply-set transformations in the
field of healthcare and medical education [1].
Materials and Methods: The strategy for innovative development in
Russia is based on implementation of intellectual potential of the domes-
tic personnel resources into the practice and economy and setting high
requirements to the quality of the professional graduate and post-
graduate education [2]. An innovative model for the development of the
healthcare system provides for close cooperation between the healthcare
system, medical science, government and business community, planning
of scientific medical research depending on the needs of healthcare ser-
vice, active introduction of the research outcome into medical practice,
as well as targeted training of specialists capable to ensure implementa-
tion of the achievements [3].
Results: The project of modernization of the Russian medical educa-
tion system spells out four priority areas:
(i). change over to an ongoing professional education;
(ii). improvement of quality of vocational education;
(iii). ensuring investment attractiveness of education;
(iv). reform of general (secondary-level) education [1].
Within the framework of the Project we consider fundamental principles
to getting the pre-university, university, postgraduate and basic medical
training programs restructured and the development of fundamentally
new generation interdisciplinary programs, focused on training and
retraining of specialists in the PPPM-related areas and also the main is-
sues arising from the implementation of the reform. In implementing
the principle of continuity of an ongoing education a model of multi-
stage training of a specialist in the PPPM-related areas is being built,
which is characterized by a stepwise process of individual development
going over (personalized maturation of the professional), while infor-
mation is learned, from one level of an ongoing training to another
one [4].
Conclusions: Implementation of the reforms of the higher medical
education will enable to achieve and maintain the quality of training
of professionals up to the worldwide standards as applicable to Hi-
Tech Leves, as well as their academic, professional and inter-regional
mobility.
Fig. 4 (abstract A72). Factors to be considered for individualized
patient profiles providing personalized therapy in HCC
patient cohort
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The European Federation of Clinical Chemistry and Laboratory Me-
dicine (EFLM) connects National Societies of Clinical Chemistry and
Laboratory Medicine and creates a platform for all European “Special-
ists in Laboratory Medicine”. EFLM provides European leadership in
Clinical Chemistry and Laboratory Medicine to national professional
societies, the diagnostic industry and to governmental and non-
governmental organizations in order to serve the public interest in
health care. EFLM currently comprises the national societies of 40
countries and represents the International Federation of Clinical
Chemistry and Laboratory Medicine (IFCC) in Europe.
The vision and mission of EFLM is to enhance patient care and improve
outcomes by promoting and improving the scientific, professional and
clinical aspects of clinical chemistry and laboratory medicine and to en-
sure effective representation of laboratory medicine both at European
Union level and to other pan-European and sub-regional bodies.
The main activities of EFLM relate to education, research, development
of the profession, requirements for competence, quality and accredit-
ation of laboratories, organisation of congresses, and publications.
The operational structure of EFLM consists of an Executive Board (EB)
and five Committees (C)
The Communications Committee is responsible for communicating
EFLM’s activities and results to its membership, related partner orga-
nizations and the public via EFLM’s website and Newsletter.
The Education and Training Committee has general responsibility for
the postgraduate training aspects of the work of EFLM in the field of
Clinical Chemistry and Laboratory Medicine focused on laboratory
medicine professionals, health care professionals and patients, in li-
aison with the Education and Management Division of IFCC, and also
with UEMS (European Union of Medical Specialists). The Committee
organizes regional and sub-regional conferences, workshops and
postgraduate continuing education courses in association with rele-
vant national societies.
The Profession Committee is responsible for matters of professional
regulation and certification (via the EC4 Register of European Special-
ists in Clinical Chemistry and in Laboratory Medicine), and the pro-
motion of the profession in Europe at government level, and to
patients and clinical users. It liaises with CEPLIS (European Council of
the Liberal Professions) and with the European Commission and Par-
liament on professional matters. It takes the lead in developing pan-
European professional and ethical standards. It also liaises with UEMS
(European Union of Medical Specialists) on the roles and responsibil-
ities of medical and scientific practitioners of the discipline.
The Quality and Regulations Committee supports the establishment of
effective accreditation schemes and quality management systems in
all European countries and liaises with ISO, CEN and the European
Accreditation body (EA).
The Science Committee focuses on promotion of research that translates
the scientific results of laboratory medicine to clinical applications and
improves patient outcomes through the appropriate use and interpret-
ation of laboratory data in clinical practice.
The committees carry out their tasks via Working Groups (WG) and
Task Finish Groups (TFG).
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Mid infrared and microwave radiation based spectroscopy and
spectro-microscopy tools techniques can detect and/or image char-
acteristic information of biomolecules and structures without the use
of any fluorescent marker or label. This approach, when fully devel-
oped, can be of huge benefit for both in vitro and in vivo diagnostics.
At the beginning, we show how microwave spectroscopy can be
used for detecting specific binding of proteins. We will present the
case of streptavidin binding to biotinylated protein A. The method of
detection was then used to monitor the adsorption of two other pro-
teins: cytochrome c and glucose oxidase on the surface of a specific-
ally designed microwave sensor. The response of the sensor was also
tested on different substrate materials such as smooth, conductive
(gold) and on rough, insulating (hydroxyapatite) surfaces [1]. The suc-
cess of detection of protein binding on these substrates will facilitate
the use of simple surfaces for cheap and fast detection of bioana-
lytes. This is in contrast to current commercially available techniques
such as surface plasmon resonance (SPR), which requires expensive
sensor chip and elaborate sample preparation. We will also discuss
how high resolution infrared spectro-microscopy can be used for
fast imaging of proteins, cells and tissues [2-4]. High brightness
picosecond fibre lasers coupled with a synchronously pumped
(SP)-optical parametric oscillator (OPO) allows very fast imaging
of disease related positive and negative biomarkers in the mid
infrared (2.5 - 14 micron wavelength, 4000-700 cm-1 frequency).
When fully developed, these techniques can potentially revolu-
tionise diagnosis at hospital outpatient services and at the
General Practitioners.
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Background: Tumor markers have been currently used only with lim-
ited indication for the clinical routine practice.
Study Aims: The main aim of our laboratory is to promote the use of
tumor markers for optimization of the diagnostic process and for
therapy choice and therapy monitoring.
Methods and Materials / Patients: Results of the serum tumor markers
from 2 000 patients monitored in the Faculty Hospital in Pilsen have
been retrospectively evaluated. The following markers have been evalu-
ated: CEA, AFP, mucin biomarkers cytokeratin soluble fragments and
proliferative tumor markers. Markers were assessed during the primary
diagnosis and during the follow-up. Serum markers were always corre-
lated with clinical status and with imaging techniques. The following
cancers were evaluated: lung, breast, colorectal and prostate cancer.
Results: Optimal algorithms were proposed pro for diagnostic opti-
mization a for therapy effect prediction and for prognosis estimation
in relationship to overall survival and disease free interval. Computer
software is used for marker evaluation. Typical case reports will be
also demonstrated.
Conclusions: Proposed multidisciplinary algorithm represents a typ-
ical example for personalized approach to the cancer patient. Clinical
and economical benefit of these proposed algorithms is significant.
Supported by Ministry of Health, Czech Republic - conceptual development
of research organization (Faculty Hospital in Pilsen - FNPl, 00669806).
A77
Modern medical terminology as a driver of the global educational
reforms
Evgeniya Tretyak1, Maria Studneva (maria.studneva@gmail.com)2,
Sergey Suchkov (ssuchkov57@gmail.com)2,3
1Clinical Hospital 86, Federal Medical Biological Agency of Russia,
Moscow, Russia; 2I.M. Sechenov First Moscow State Medical University,
Trubetskaya Str. 8-2, Moscow, 119991, Russia; 3A.I. Evdokimov Moscow
State University of Medicine and Dentistry, Delegatskaya Str. 20/1,
Moscow, 127473, Russia
Correspondence: Evgeniya Tretyak (tretyak_eugenia@mail.ru) – Clinical
Hospital 86, Federal Medical Biological Agency of Russia, Moscow, Russia
The EPMA Journal 2016, 7(Suppl 1):A77
Keywords: Modern medical terminology, Encyclopedic dictionary,
Paradigm shift, Educational reform
Predictive, preventive and personalized medicine (PPPM) meets the
current need in the development of innovative approaches to the
training of interdisciplinary medical specialists which requires educa-
tional reform which paves the way to the creation of innovative in-
frastructure. The starting point is the restructuring of terminological
base as the understanding of modern medicine is impossible without
understanding the terminology.
Scientific objectives: Innovations in science and advanced technolo-
gies are accompanied by the burst of novel terms. They undergo nu-
merous modifications, improve and become more complicated for
being understood. The extent of this renewal is not in line with men-
tal status of specialists thus obstructing the understanding of current
progress. This determines the need of the adequate representation
in ethnical languages.
In Russian scientific community, English glossaries are amongst the
main sources to renew medical vocabulary (more than 90 % of scien-
tific datasets is published in English). Regular medical dictionaries are
unable to cover the spectrum of conceptual terminology as vocabu-
lary capacity is significantly limited.
A similar situation is observed in the field of textbook preparing and
writing on novel hi-tech medical disciplines including PPPM. The princi-
ples and technological armamentarium of this interdisciplinary global
model are an enigma for the medical community. This requires the
development of novel vocabularies and formal dictionaries which in-
corporate conceptual terminology, explanations and illustrations.
Technological approaches: We attempt to create an English-Russian
Series of Encyclopedic Dictionaries regarding PPPM and related and
interdisciplinary areas to secure the understanding and comprehend-
ing of terms and their combinations.
Results interpretation: Modern medical terminology (MMT) puts for-
ward PPPM strategies. It will serve as an impulse for further advance-
ments by connecting scientists all across the world and creating an
environment for information exchange, generation of new ideas and
acceleration of applications. MMT uncovers medical innovations and
potentially changes the way treatments are discovered and used. It
propagates PPPM concept among healthcare professionals, govern-
mental institutions, educators, and public. It creates a consolidated
platform and provides implementation of the achievements for an
effective advancing of healthcare.
Expert recommendations: MMT creates new measures to conduct
important information for all PPPM relevant persons and shifts the
paradigm from delayed reactive care to predictive and preventive
medical care.
A78
Juvenile hypertension; the relevance of novel predictive,
preventive and personalized assessment of its determinants
Francesca M. Trovato1, Giuseppe Fabio Martines1, Daniela Brischetto1,
Daniela Catalano1, Giuseppe Musumeci2, Guglielmo M. Trovato1
1Department of Clinical and Experimental Medicine, University Hospital
of Catania, Catania, Italy; 2Department of Bio-Medical Sciences, Human
Anatomy and Histology Section, School of Medicine, University of Cat-
ania, Catania, Italy
Correspondence: Guglielmo M. Trovato (guglielmotrovato@unict.it) –
Department of Clinical and Experimental Medicine, University Hospital of
Catania, Catania, Italy
The EPMA Journal 2016, 7(Suppl 1):A78
Keywords: Environmental risk factors, Behavioral factors, Nutrition,
Arterial hypertension, Predictive preventive personalized medicine,
Obesity, Salt intake
Arterial hypertension can have its origins in juvenile behaviors and
factors. The most relevant are familiar and environmental risk factors,
overweight-obesity, and salt intake. Since several other environmen-
tal and behavioral factors can interfere we challenged if overweight-
obesity, smoking, alcohol, sleep deprivation, coffee and salt intake
are associated with arterial hypertension.
Methods: A group of consecutive youngster were enrolled and
assessed by clinical visit and interview, measuring blood pressure by
an electronic oscillometric device in two different positions, sitting
and standing, and then, 5 minutes after standing and one week
apart. Body weight and height were measured, and BMI calculated;
salt intake was categorized as <3.0 g/day, >3.0 < 6.0 g./day and ≥
6.0 g/day. Cigarette smoking, alcohol habits (at least twice a week >
20 g/day), habitual use coffee and caffeine beverages use (any quan-
tity), and sleep deprivation (defined by the 25th lower percentile of
average of hours of sleep in the week of observation) were recorded.
Hypertension was defined as systolic BP ≥ 140 mmHg and /or dia-
stolic BP ≥ 90 mmHg. Odds ratio was calculated as the hazard of the
factors vs. hypertension.
Results: 833 youngsters, age 23.40 ± 5.39 years 1200 were 14-20
years old (adolescents) age 18.31 ± 1.96 years, 1282 were 21-28 years
old age 23.57 ± 2.23 years and 546 were 29-35 years old age 32.33 ±
2.17 years were enrolled; men were 1167, women were 1666. The
most relevant risk factor for higher blood pressure is overweigh-
obesity (OR 3.815; 95 % CI 2.329-6.249), cigarette smoking (OR 1.949;
95 % CI 1.235-2.415), coffee and caffeine beverages use (OR 1.727;
95 % CI 1.235-2.415), alcohol habits (OR 1.462; 95 % CI 1.093-1.956),
sleep deprivation (OR 1.441; 95 % CI 1.077-1.930), and salt use above
6 g/day (OR 1.423; 95 % CI 1.063-1.904). By MLR these factors explain
the level of systolic blood pressure.
Conclusion: Overweight-obesity is still the most relevant risk factor
of arterial hypertension also in youngsters. The concurrent, less
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relevant effectors, apart cigarette smoking, alcohol, salt intake and
caffeine, can be many, including sleep deprivation, which is emer-
ging as an indicator of environmental and behavioural health
unfavourable effects. A comprehensive articulated predictive, pre-
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Proteomarkers Biotech (PMB) is an innovative biotechnology-oriented
company specialized in the non-invasive prenatal test of fetal health
and pregnancy complications. The main goal of the company is the
commercial exploitation of the state-of-the-art technologies of proteo-
mics and mass spectrometry, which nowadays used on the biomarker
identification and validation [1-3]. PMB will develop, produced and pro-
mote to the market innovative diagnostic kits in competitive prices, tar-
geting a dominant position in the local and international marker.
The produced kits of PMB concern with the detection and quantita-
tion of proteins (biomarkers) in the maternal peripheral blood and
they suggested a possible embryonal abnormality (Down syndrome,
Turner syndrome, Klinefelter syndrome, etc) or the possibility of de-
velopment pathological situations during pregnancy such as pre-
eclampsia, premature delivery, intra-uterus infections etc. Through
these kits of prenatal test, PMB introduce a series of innovations and
improvements in technological and financial level, as well as in the
time of result receipt [4, 5]. Namely:
1. Reliability: High (>95 %) for all pregnancies independently of
the risk
2. Sampling: peripheral blood
3. Low sample volume: 10 μl
4. Technology: Mass spectrometry (high sensitivity and specificity)
5. Single tube diagnosis of multiple disorders (embryonic
abnormalities with simultaneous existence of pregnancy
complications)
6. Fast (next day result)
7. Early application in pregnancy (week 10th-12th)
8. Low cost: at least 30 % lower compared to current methodologies
Potential customers of PMB products are all pregnant women who
want fast, low cost and with high accuracy to determine whether
their fetus suffering from a chromosomal abnormality or if they are at
risk of developing complications during pregnancy. PMB will supply kit
with diagnostic laboratories with MS who will perform these tests.
The main objective of PMB is the rapid establishment in Greek mar-
ket as first step of its development and a-proof-of-concept at a mar-
ket level its rapid expansion into the European and international
market. It is mentioned that PMB has close relationships with com-
panies and entities providing health services both in Greece and
abroad.
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In the context of human reproduction research, it is widely ac-
cepted that the “holy grail” of fetal diagnostics, is the discovery
of biomarkers present in the individuals’ serum/plasma that could
accurately predict the occurrence of fetal abnormalities and/or
pregnancy complications. Maternal blood is the biological fluid
currently attracting attention of researchers, as it aspires to attri-
bute evolution in non-invasive prenatal testing (NIPT), thus im-
proving our understanding over the feto-maternal pathologies.
Nowadays the application of state-of-the-art technologies of pro-
teomics and mass spectrometry, have been extensively used for
biomarker identification on the first trimester of pregnancy pro-
ducing results concerning a variety of fetus abnormalities (Down
Syndrome, Turner Syndrome, Klinefelter syndrome etc.) and preg-
nancy complications (preeclampsia, intra-uterus infections, IUGR
etc.). Down syndrome (DS) is the most common chromosomal ab-
normality in pregnancy. Application of proteomics for the identifi-
cation of potential biomarkers for the NIPT of DS has revealed
that the protein Serum amyloid-p (SAP) could act as a reliable
biomarker for DS fetuses at the 10th-12th and 15th-16th week of
pregnancy [1, 2]. Mass spectrometric quantitative analysis of SAP
in maternal plasma indicated that at the 10th-12th week of preg-
nancy SAP was increased by a mean of 20 % in DS pregnancies
compared to controls, while at the 15th-16th week of pregnancy
SAP was increased by a mean of 40 % [2, 3]. Related to Turner
syndrome (TS) proteomic analysis of maternal plasma revealed
that 9 proteins were significantly increased in the plasma of
women carrying TS fetuses, whereas 3 were found to be de-
creased [4]. Furthermore, 3 proteins were found to be up-
regulated in samples obtained from pregnancies with Klinefelter
syndrome foetuses, whereas 4 proteins were down-regulated
when compared to proteins detected in samples from normal
foetuses. Related to the prevention of pregnancy complications, a
number of proteins were found up-regulated in the maternal
plasma at the 10th-12th in pregnancies which developed pre-
eclampsia later in pregnancy. Proteomics offers a useful approach
for the identification of biomarker, for prediction of fetal abnor-
malities and prevention of pregnancy complications, while the
quantitative measurement of these biomarkers by mass spectrom-
etry in maternal plasma will provide a reliable, multiplex, faster
and cheaper screening NIPT approach [5].
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Goal
ZENITH aims to design and validate a new integrated ecosystem for
an integrated care for heart failure (HF) patients including related co-
morbidities, defining a new organizational model with the ability to
improve quality of care for patients and to support the sustainability
of the healthcare systems enabling continuity of care.
Scientific objectives:
ZENITH pursues the following objectives:
1) Stratification model and categorization of patients.
2) Personalization of the clinical interventions for HF patients dealing
with their co-morbidities simultaneously.
3) Development of a unique ICT platform to be used by all the
stakeholders.
4) Design of patient-oriented services according to the categorization
of patients.
5) Use of the social workers into the integrated ecosystem.
6) Define a new organizational model to provide a complete com-
munication and coordination between GPs, specialist, patient and
carers.
7) Improve the evidence on health outcomes, QoL and care efficiency.
Technological approach
ZENITH is based in one ICT platform capable of collecting data from dif-
ferent centres (primary care, hospitals, outpatient clinics and patients’
home) and different stakeholders (general practitioners, specialists,
nurses, social workers, patients and relatives). Different sources provide
information to the ICT platform: typical parameters (i.e. blood pressure,
weight, heart rate), implanted cardiac devices information, long-term
subcutaneous recorders (24hx7dx365d), medium-term wearable re-
corders, hospital information systems and primary care data.
Impacts
The achievable impacts thanks to the use of the integrated ecosys-
tem model proposed in ZENITH are:
1) Reduction in: i) all cause heart failure 30-day readmissions, ii) walk-
in clinic visits in primary care, iii) the emergency department visits,
and iv) days spent in care institutions.
2) Increase medication adherence at 1 year.
3) Improved cooperation between primary care and specialists and
the interaction between patients, their carers and the social carer.
4) Reinforce primary care and specialists’ medical knowledge with re-
spect to co-morbidities and poly-pharmacy.
5) Use an ICT system with all data available fully integrated, well or-
ganized, with clear information and reports to: i) help clinicians to
make decisions with a global view of the HF and co-morbidities, ii)
help patients to be remotely completely monitored with better QoL
and less decompensations, iii) make sustainable the existing health-
care model, and iv) strengthen European industrial position in ICT
products and services with new business areas and IPRs.
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Decision support system
The global prevalence of diabetes is 9 % of the world’s population;
TD2M represents the 90 % of the cases [1]. The TD2M’s condition is
the main risk factor for death and no-fatal complications; it causes a
large burden to patients, families and the healthcare system. To re-
duce the long terms effects of this pandemic disease a strategy
based on predictive, preventive and personalized medicine (PPPM) is
required: develop risk calculation tools for diabetes onset and com-
plications and develop early screening and intervention programs.
This abstract describes the achievements of the MOSAIC project that
developed mathematical models to improve the current standards
and practice for diagnosis of T2DM and also pre-diabetic states (IGT
and IFT) as well prognostic tools to assess the risk of complications
in diagnosed cases. The models have been trained using a large
European datasets.
This research is based on three pillars: Create models to discover new
indicators for onset and evolution of the disease, stratify the risks at
population level and integrate the tools into the existing decision sup-
port systems of hospitals, clinical centres and health agencies.
The prediction of diabetes evolution is based on a Cox survival
model and provides the curve of patient’s risks from 2 to 12 next
years. The model was assessed with the Areas Under the ROC Curve
(AUCs) trough 100 internal train/test splits and the external valida-
tion obtaining, in average AUC = 0.90, which outperforms the scores
obtained by the “state of the art” models such as FINDRISC and
FRAMINGHAM (AUC = 0.77) [2, 3].
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The complications models exploit Logistic Regression (LR) and Naïve
Bayes to predict the onset of Retinopathy, Neuropathy or Nephropathy,
at 3, 5 and 7 years from the first visit at the hospital. The predictive
power of our approach is estimated with a leave-one-out cross-
validation, on witch AUC varied between 0.832 (LR, Retinopathy)
and 0.647 (LR, Neuropathy) for 3 years horizon.
The predictive models have been integrated in a Web based plat-
form that connects to the clinical data-warehouse of the clinics to be
used in the following contexts: screening and monitoring of popula-
tion (health agency), diagnostic and risk assessment (primary care),
and evolution and management of the disease (secondary care).
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Currently, the important role of antioxidant system violations, includ-
ing the thiol-disulfide (SH/SS) equilibrium of blood in the pathogen-
esis of diabetes is proved. We have developed an original method
for screening drugs, based on the study of their in vitro effects on
SH/SS blood ratio, where whole blood with anticoagulant (EDTA) was
incubated in thermostat (37 °C) in the presence of drugs for 1 h, the
control samples was incubated with saline [1]. Determination of SH-
and SS-groups in hemolisate was done by spectrophotometry. In
processing the data performance SH-groups and SH/SS ratio in the
control and experimental samples were compared. In controlled clin-
ical trials in patients with endometriosis it was demonstrated that
using the proposed method for companion diagnostics have im-
proved the effectiveness of personalized hormone treatment 2 times
in comparison with standard one [2]. In studying the effect of various
drugs and forms of insulin and oral hypoglycemic agents (Diabeton,
Glibenclamide, Glurenorm, Metformin) in different doses on the SH/
SS ratio of the blood of patients with diabetes has been shown that
the response of each patient was purely personal [3]. For each pa-
tient, it was possible to select the optimal drug and dose, which usu-
ally do not coincide with therapeutic ones, appointed on the basis of
indicators of blood glucose levels. The method can be used for per-
sonalized therapy of diabetes and allows evaluating the dynamics of
the sensitivity to the drugs during treatment as well as for patient-
based drug discovery. The method has a huge market potential and
is currently used in laboratories in Russia and the United States. Con-
trolled clinical trials of this technique for patients with diabetes are
necessary.
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The original method for drug screening based on it in vitro effect on
blood thiol-disulfide (SH/SS) ratio was proposed for personalized
therapy [1]. The study involved 325 patients with chronic hepatitis C
(HCV), chronic bronchitis, endometriosis and non-small cell lung can-
cer (NSCLC). The controlled trials shown 3-fold increase of HCV viral
response rate after personalized therapy with interferon (IFN) com-
pared to standard (74.2 % vs. 25.0 %) [2], 2-fold increase efficiency of
personalized hormonal therapy of endometriosis compared to stan-
dard (85.4 % vs. 42.5 %) and 2-fold increase frequency of partial
remission rate of NSCLC after personalized cytostatic therapy in com-
parison with standard one (36 % vs.17 %) [3, 4]. The sensitivity of the
method was 89.2 – 89.8 %, and its specificity – 94.6 %. The incidence
of adverse effects of IFN was decreased 6 times compared to stand-
ard therapy (12 % vs. 72 %). At chronic bronchitis the incidence of
unsatisfactory clinical results or progression was three times less
(11 % vs.33 %), the incidence of unsatisfactory bacteriological results
was 4 times rarely (7 % vs. 28 %), and the rate of side effects was
more than two times less (10.5 % vs. 22.8 %) after personalized versus
standard therapy by the same antibiotics [3, 4]. Thus, proposed method
of screening drugs using SH/SS-test can be used to personalize therapy
of human diseases by antibiotic, hormonal, antiviral, cytostatic and im-
mune preparations to improve efficiency and overcome resistance to
drugs, search the best drugs, their doses and combinations, reducing
the frequency of side effects and complications.
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Scientific objectives: The main aims were to investigate the impact
of pain in the temporomandibular joint (TMJ) and masticatory
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muscles on daily living; to investigate the progression of radiographic
signs of bone destruction in the TMJ of patients with rheumatoid
arthritis (RA) and wether this progression is related to the presence
and levels in the blood of inflammatory mediators and markers; to
relate the clinical findings to disease activity in juvenile idiopathic
arthritis (JIA) patients; to elucidate the effect and efficacy of various
TMJ treatment modalities.
Technological approaches. During the development of predictive,
preventive, and personalized medicine many new and sensitive
methods for earlier detection of bone destruction has been used in
the management of TMJ disorders [1].
Results interpretation: A population based study showed a 47 %
rate of TMJ clinical involvement and indicated that TMJ pain/discom-
fort exerts a negative influence on ADL and is related to the bio-
chemical markers of bone turnover and the 25(OH)D level [2]. In
malocclusion patients, TMJ dysfunction suggests the need for ortho-
dontic treatment [3]. In RA patients, the electromyographic activity of
masticatory muscles during TMJ movement was higher than in
healthy subjects. A long term (7-8 yrs) investigation suggests that
high levels of plasma concentration of the tumor necrosis factor, of
erythrocyte sedimentation rate and of thrombocyte particle concen-
tration predict progression of erosions and bone loss in the TMJ of
patients with RA, while serum concentrations of serotonin seem to
have an indirect effect. A long-term (5 yrs) study showed an in-
creased frequency of fibrillations and fibrous adhesions as patho-
logical findings following TMJ arthroscopy. Arthroscopic treatment of
TMJ disorders is conducive to favourable long-term results with re-
gard to increasing the maximum interincisal opening, reducing pain
and eliminating TMJ dysfunction [4].
Outlook and Expert recommendations: The conduct of long-term
studies represents an important contribution to predictive and pre-
ventive medicine. The assessment of TMJ pain, the biochemical
markers of bone metabolism, mediators and treatment results helps
to monitor the disease process. Interdisciplinary approach is import-
ant for the selection of correct personalized treatment modality and
hence a better quality of life.
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The health professionals recognize the importance of ensuring peo-
ple to have both adequate and reliable access to essential medicines
and diagnosis while traveling. Health authorities need to know what
to prioritize and ensure that the exiting basic health care system is
able to adequately serve the needs of the traveling people. The
history of travel medicines is relatively recent. The Faculty of Travel
Medicine, Australasian College of Tropical Medicine was established
in 2000 as the first faculty of Travel Medicine globally [1].
Although the history of Essential Medicine (EM) is recent considering
that aspirin introduced in 1897 is the first synthetic pharmaceutical,
and is the first EM aiming to provide and satisfy the health care
needs of the majority, the concept of EM has been already recog-
nized globally [2]. In 1977, the WHO launched the “Model List of EM”,
and identified 208 individual medicines which could provide safe,
cost-effective and time-efficient treatments for common diseases [2].
With the arrival of Big Data and many Biomarker claims, along with
EM, developing Essential Diagnostics (ED) will be critical for Prevent-
ive, Predictive and Personalized Medicine (PPPM) [3]. Developing
such a Model List of ED would provide an opportunity to harness the
advanced diagnostic technology and link it with health policies, ac-
countable to global communities [2, 3].
Suboptimal Health Status (SHS) is a pre-clinical physical status be-
tween health and disease, and is characterized by the perception of
health complaints, general weakness, and low energy. It is regarded
as a subclinical, reversible stage of chronic disease [3-5]. SHS is also
the one of the most common subjective, self-measurable health phe-
notypes during and after people’s traveling.
Author proposes how we combine the merits of EM, ED, and SHS to
apply them in PPPM practice.
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A full characterization of consistent phenotypes which defines the
general population is the basic step to individual difference nor-
malization in predictive, preventive and personalized medicine
(PPPM). Self-claimed normal healthy status might not represent the
real healthy condition due to the facts that asymptomatic subjects
may carry chronic diseases at their early stage, e.g. atherosclerosis,
diabetes mellitus and hypertension. Currently, treatments for chronic
diseases are implemented after clinical diagnosis, which is a very
much delayed-approach from the perspective of PPPM [1]. This ab-
stract examples the suboptimal health status (SHS) which is a new
PPPM challenge in a cohort of people with ambiguous health
complaints, e.g. general weakness, chronic fatigue syndrome, and
myalgic encephalomyelitis [1-4]. An example of using Copenhagen
Psychosocial Questionnaire (COPSOQ) in combination with Subopti-
mal Questionairee-25 (SHSQ-25) to assess job-related psychosocial
stress will be reported. The mean value of the five scales of COPSOQ
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and distribution of plasma cortisol and mRNA expression of GRa/GRb
between the high and low levels of SHS groups were compared
using multiple linear regression analysis. We have identified 3 factors
that are predictive of SHS, i.e. 1) demands at work, 2) interpersonal
relations and leadership, and 3) insecurity at work. Higher levels of
plasma cortisol and GRb/GRa mRNA ratio were observed in the high
SHS-score group [2]. SHS is correlated with decreased mRNA expres-
sion of GRa [2] and also n-glycan profiling [5]. The study confirmed
the association between chronic psychosocial stress and SHS, dem-
onstrating that improving psychosocial work environment may re-
duce SHS and prevent chronic diseases with the PPPM approach.
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Scientific objectives: An estimated 2.7 million new cancer cases and
7.6 million cancer related deaths were reported worldwide in 2008
and incidences are increasing. It is well accepted that early cancer
diagnosis can improve survival, thus there is a great need and antici-
pation to identify novel biomarkers for cancer diagnosis at the
earliest possible stage, which can ideally be integrated in minimally
invasive diagnostic assays. Epigenetic changes are a hallmark of
cancer can be used as markers for detection of circulating tumor
DNA in serum/plasma as well in saliva samples. In addition cancer
onset and progression produces mutated or aberrantly expressed
proteins generally also termed as tumor associated antigens (TAAs)
which are able to act as antigens and evoke an immune response
which results in the production of autoantibodies. These autoanti-
bodies and the early DNA methylation changes during neoplastic trans-
formation are able to be detected months or years before the clinical
diagnosis of cancer and can therefore be used as biomarkers for the
early diagnosis of cancer.
Technological approaches: We have setup genome- and immunome-
wide biomarker-discovery as well a targeted technologies using multi-
plexed technologies for validation of these markers. Combining the
relevant technologies we call these MethPipe and PepPipe for enabling
us streamlined biomarker-development for DNA-methylation and
Antibody-based diagnostics.
Results interpretation: Plasma derived cell free DNA methylation
maker qualification for early diagnosis of lung cancer has been
conducted successfully enabling AUC = 0,85-0,92. Similarly the
serum-autoantibody based biomarker discovery enables high cor-
rect classification (AUC >0,9) for distinguishing cases vs control
for the big 4 cancer entities. Thus as exemplified both cell free
DNA-methylation analyses and antibody-profiling technologies
have a high potential for minimally invasive diagnostics.
Outlook and Expert recommendations: These strategies for enabling
minimally invasive testing of patients are well suited for disease bio-
marker definition – and will be useful for enabling personalized
medicine by qualification of diagnostic, prognostic, and predictive
biomarkers.
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In the EU, rare diseases (RDs) are defined as life threatening and
debilitating diseases with a prevalance of less than 5 per 10.000
persons. Even if the number of individuals with a specific disease is
low, there are about 8.000 RDs that affects millions of individuals
worldwide. Unfortunately for health care systems, RDs are “orphan”
diseases and there is still a lack of capacity building for timely diag-
nosis, management and treatment. Thus national and international
collaborations are crucial to reach an adequate number of patients
for biomedical research and clinical trials [1]. In this respect biobanks
are valuable infrastructures where patient samples and associated
clinical and personal data can be stored with proper governance cov-
ering quality assurance of sample storage and ethical guidelines for
acquisition of and access to samples and data [2].
Since more than 80 % of RDs are monogenic, identification of new
disease genes and their functional annotation to understand the dis-
ease pathogenesis, will lead to the design and development of new
targeted/personalized therapies relying on accurate stratification of
patients based on “omics” data sets [3]. Here biobanks play an im-
portant role in securing different biological samples from the same
individual. Moreover banking samples from patients with a wide
spectrum of phenotypes provide insights into the genetic and other
modifiers of the disease phenotype and this is an added value for
designing a personalized approach for treatment. Today there are
different RDs consortia such as RD-Connect, IRDIRC, EuroBiobank,
RDCRN through these cooperations, harmonization of ethical guide-
lines and SOPs will become available all to the benefit of the RDs
patients and their individualized treatments in the near future [4].
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